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ABSTRACT OF THE DISSERTATION 
Molecular Mediators of Acute and Chronic Itch in Mouse and Human Sensory Neurons 
by 
Manouela Vesselinova Valtcheva 
Doctor of Philosophy in Biology and Biomedical Sciences 
Neurosciences 
Washington University in St. Louis, 2018 
Professor Robert W. Gereau, IV, Chair 
 
Itch is a distinct sensation that arises from the activation of small-diameter pruriceptive 
nerve fibers innervating the skin. Recent strides in the field have identified several histamine-
dependent and -independent pruriceptive pathways and receptors that contribute to acute and 
chronic itch. The work presented in this thesis further investigates the molecular mechanisms 
involved in the signaling, development, and sensitization of itch in mouse and human. Most 
pruritogen receptors are Gq-Protein Coupled Receptors (GqPCR), which canonically activate 
protein kinase C (PKC); however, little is known about whether specific PKC isoforms regulate 
itch. The first study in this thesis demonstrates that the isoform PKCδ contributes to histamine-
induced scratching, but not histamine-independent itch. Our studies show that PKCδ is expressed 
in dorsal root ganglia (DRG), where it mediates sensory neuron responses to histamine.  
 To investigate the mechanisms behind a common form of chronic pruritus, the second 
study in this thesis applied a mouse model of dry skin itch to test changes in sensory neuron 
structure and function. We found that dry skin was marked by a significant increase in epidermal 
nerve fiber innervation independent of scratching. Furthermore, dry skin was associated with a 
selective increase in non-peptidergic, Ret-positive fibers and a functional expansion of the 
proportion of chloroquine-sensitive neurons. Epidermal hyperinnervation and increased growth 
factor levels in the skin of patients with pruritic skin diseases suggest a potential role for 
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neurotrophic factors (NTFs) in itch. In our third study, we tested the hypothesis that NTF signaling 
modulates pruritogen-evoked itch. Pretreatment with nerve growth factor (NGF) selectively 
potentiated histamine-induced scratching and increased the proportion of histamine-responsive 
sensory neurons. Artemin pretreatment, on the other hand, potentiated scratching induced by 
chloroquine, and increased the proportion of chloroquine-responsive neurons. Interestingly, 
aberrations in endogenous TrkA-NGF signaling significantly impacted normal pain sensation, but 
did not play a role in histamine- and chloroquine-induced itch.  
In the final study of this thesis, we developed a protocol to surgically extract human DRG 
from organ donors and culture dissociated human primary sensory neurons. Using this approach, 
we performed functional studies to characterize the pruritogen- and algogen- responsive sensory 
neuron subpopulations in humans. We found that NGF and artemin pretreatment did not change 
histamine and chloroquine responses in vitro, indicating a potential functional difference between 
mouse and human sensory neurons.  
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Chapter 1 
Introduction 
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The clinical burden of itch 
Itch, or pruritus, is a sensation that arises from small diameter nerve fibers innervating the 
skin and mucosa [1]. Normally, itch is an unpleasant sensory and emotional experience that 
evokes the desire to scratch, thus providing the necessary drive to avoid actual or potential skin 
damage. But if it becomes pathological, itch can lead to severe skin injury and emotional distress. 
Chronic pruritus, defined as itch that lasts longer than 6 weeks, affects more than 15% of the 
world’s population and can lead to sleep disturbances, severe anxiety, self-mutilation, and 
impaired overall quality of life that may be comparable to chronic pain conditions [2-4]. Major 
causes of chronic pruritus include dermatological diseases such as atopic dermatitis and 
psoriasis, where itch is reported by more than 70% of patients [4-7]. Neuropathic causes of 
chronic pruritus include conditions such as post-herpetic neuralgia and notalgia paresthetica [8]. 
Systemic diseases such as HIV, uremia due to kidney failure, cholestasis due to liver failure, and 
lymphomas are also associated with a high prevalence of itch [4, 9, 10]. Drug-induced pruritus 
presents as a side effect of the anti-malarial drug chloroquine, and more commonly the epidural 
application of opioids [11-13]. Psychogenic pruritus is another cause of chronic itch, but remains 
poorly characterized in the general and psychiatric populations [8].  
Recent advances in basic and clinical research have begun to uncover some of the 
molecular mechanisms underlying pathological itch, though much remains unclear, and the 
current treatment options for patients with chronic pruritus are limited in number and efficacy [3, 
14]. First-line treatment often consists of topical remedies such as emollients, topical anesthetics, 
or coolants, and over-the-counter antihistamines, although clinical data on their efficacy is limited. 
Itch secondary to skin disorders is often associated with substantial skin inflammation and 
infiltration by immune cells, and can respond to immunomodulatory treatments including 
corticosteroids and biologics such as TNF-alpha or interleukin blockers [3]. Neuropathic and 
systemic itch may respond to neuro-modulatory medications such as gabapentin and pregabalin, 
selective serotonin-reuptake inhibitors (SSRIs), or mu-opioid receptor antagonists. However, 
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uremic and cholestatic pruritus respond best to resolution of the systemic insult by kidney or liver 
transplant. Ultimately, there is no magic bullet for the treatment of chronic pruritus. Many of the 
available therapies provide only limited relief and are associated with significant side effects, 
further underlining the importance of research to expand the current understanding of pruriceptor 
physiology and identify novel potential treatment targets.  
 
The neurobiology of itch 
 Primary sensory nerve fibers can be broadly categorized into three groups: fast-
conducting myelinated Aβ fibers, thinly-myelinated Aδ fibers, and slow-conducting unmyelinated 
C fibers. Pruriceptors, much like nociceptors, consist of a subpopulation of small diameter C-fibers 
and some Aδ fibers that innervate the epidermis and upper part of the dermis [1, 15, 16]. 
Microneurography studies in humans have been particularly useful for identifying subtypes of itch-
sensitive fibers as they allow researchers to directly correlate sensory fiber activation with the 
reported perceptions of itch and pain by human subjects in real time. Early studies by Handwerker 
and Schmelz discovered that superficial skin application of the well-known pruritogen histamine 
activated a population of C-mechano-insensitive fibers, as well as a population of C-mechano-
heat sensitive fibers [17-19]. These histamine-sensitive fibers responded to other inflammatory 
compounds known to sensitize nociceptors, including prostaglandin-E2 and serotonin, and most 
were also responsive to capsaicin [19]. While histamine plays a key role in allergic and wheal-
and-flare reactions, many forms of clinically-relevant itch appear to work via histamine-
independent mechanisms. Microneurography studies using the spicules of cowhage (mucuna 
pruriens) have demonstrated another distinct subset of C-mechano-sensitive nociceptive fibers 
that are activated to produce histamine-independent pruritus [20, 21].  
In the skin, pruriceptive signals are transduced at the peripheral terminals of sensory 
neurons whose cell bodies are located within dorsal root ganglia (DRG) or trigeminal ganglia (TG). 
Information is then relayed via central projections which synapse onto cells in lamina I and II of 
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the spinal cord dorsal horn or spinal trigeminal nucleus in the brain stem, where peptide signaling 
through the gastrin-related peptide receptors (GRPR) and B natriuretic peptide (BNP) receptor 
NPRA play a key role [1, 22-24]. Pruriceptive information is then relayed contralaterally via distinct 
subsets of spinothalamic tract neurons that project to nuclei within the thalamus, and 
subsequently to higher cortical structures [25-28].  Although the itch neuraxis shares the 
neuroanatomical structure of pain processing, the mechanisms behind the transmission of these 
two distinct sensations are still under investigation.   
 
Itch receptors at the primary afferents 
Histamine is perhaps the most well-known and widely-studied pruritogen, but also plays 
prominent physiological roles in sleep-wake cycles, vasodilation, gastric acid secretion, and 
immune cell function. Histamine receptors are G protein-coupled receptors that can be classified 
into four subtypes (H1-4) and can be found throughout the nervous system and many non-
neuronal tissues. H1R is the main histamine receptor expressed on primary afferents, but can 
also be found in neurons in the central nervous system (CNS), smooth muscle cells, and 
endothelial cells [29-31]. H2R is expressed in many cell types, including gastric parietal cells 
where it is a key mediator of gastric acid release. H3R couples mainly to Gαi/o and acts as an 
autoreceptor throughout the nervous system [30]. H4R is also coupled to Gαi/o and has a major 
role in regulating immune cell function, but whether it has a role in the nervous system remains 
under investigation [32, 33]. Studies using highly selective pharmacological antagonists have 
demonstrated that H1R is the main receptor responsible for itch sensation and axon reflex 
neurogenic vasodilation that results in the wheal and flare induced by histamine skin prick [34, 
35]. Although H4R has not been investigated as extensively in humans, preclinical studies 
demonstrate that H4R antagonists were also able to reduce histamine-induced scratching in mice 
[3, 36-42]. Functional studies of sensory neurons utilizing ratiometric fluorescent calcium 
indicators demonstrate that histamine activates 10-15% of rodent DRG neurons [43-45].  
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Recent studies have identified several histamine-independent itch pathways that signal 
through receptors in the mas-related G protein receptor (MRGPR) family. This is a diverse family 
of receptors, consisting of the conserved subfamilies D to G, and several subfamilies found only 
in rodents (A, B, C, and H) or primates (X). Initial studies found that most MRGPR subtypes are 
expressed almost exclusively in a small subset of sensory neurons that bind the plant lectin 
isolectin B4 (IB4) [46]. A key study using Mrgpr cluster knock-out mice, which lacked most MrgprA 
and MrgprC genes, found that despite normal pain sensation, itch responses to chloroquine were 
greatly reduced. Chloroquine is an anti-malarial drug that induces robust itch in mice and can 
induce itch in humans of African descent [13]. Experiments in heterologous cells found that 
chloroquine asserts its effects by activating the MrgprA3 receptor [47]. Chloroquine-responsive 
DRG neurons were found to comprise a very small subset of sensory neurons (approximately 
5%), and also responded to histamine and the transient receptor potential (TRP) channel V1 
agonist capsaicin. The same group also found that MrgprC11 is a receptor expressed in a subset 
of the MrgprA3-positive cells and is activated by the peptides SLIGRL and bovine adrenal medulla 
8-22 pepetide (BAM8-22) to induce itch in rodents [48]. 
As mentioned previously, MRGPRX subfamily receptors are found exclusively in primates 
and in humans they are mostly restricted to DRG and TG tissues. Studies using heterologous 
systems demonstrate that MRGPRX1 can be activated by the peptides BAM8-22 and BAM1-22 
[49, 50].  MRGPRX1 can also be activated by chloroquine, though at a much higher EC50 [47]. 
BAM8-22 injection induced itch along with a stinging sensation in human volunteers, supporting 
a role for MRGPRX1 in the signaling of itch in humans [51]. While MRGPRX1 is not a true human 
ortholog of MrgprC11 or MrgprA3, it may play a key role in the signaling of non-histaminergic itch 
in humans. MRGPRX2 RNA has been identified in both DRG and mast cells, though its potential 
role in itch remains unknown [52-55]. No ligands have been described yet for MRGPRX3 and 4 
subtypes, but a study overexpressing MRGPRX3 under the β-actin promoter in rat found several 
skin and eye abnormalities [56, 57]. 
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MrgprD is another pruritogen receptor subtype that is conserved in rodents and primates, 
and is found specifically in non-peptidergic C-fiber nociceptors that synapse onto lamina II 
neurons of the spinal cord dorsal horn [58]. A subset of MrgprD-positive neurons can be activated 
by β-alanine, an amino acid commonly found in muscle building supplements, to induce itch in 
both mice and humans [59]. Some MrgprD-positive neurons are also heat- and mechano-
sensitive, but the complexities of this subpopulation are not yet well characterized [60-62]. In 
addition to the histamine and Mrgpr family receptors, various other itch receptors have been 
discovered, including proteinase-activated receptors (e.g. PAR2), toll-like receptors (TLR7), 
interleukin receptors (IL-31), and thymic stromal lymphopoetin receptor (TSLPR) [63]. 
 The expression pattern of pruritogen receptors identifies at least three functionally distinct 
subtypes of pruriceptive fibers (Fig. 1) [64-66]. Calcium imaging studies have identified a 
histamine-responsive subgroup (Fig.1A) and a β-alanine-responsive group (Fig. 1B), representing 
two distinct subpopulations that do not respond to other pruritogens [43, 47, 59, 67-69]. The third 
pruriceptor subtype is a chloroquine-responsive group, representing only 5-10% of sensory 
neurons. This group includes all SLIGRL/BAM8-22 responsive neurons. In addition, more than 
half of all chloroquine-sensitive neurons also respond to histamine (Fig. 1C). Interestingly, 
 
Figure 1. Subtypes of pruriceptive fibers. A. Histamine-responsive subset of 
pruriceptors is functionally linked to TRPV1. B. β-alanine-responsive cells are a 
distinct subset of MrgprD+ non-peptidergic neurons. C. MrgprA3-expressing 
neurons are both TrkA/Ret+ and represent a subset of pruriceptors that can 
respond to a number of pruritogens.  
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ablation of MrgprA3-positive neurons had no effect on pain behavior, but caused profound deficits 
in scratching induced by chloroquine, SLIGRL, BAM8-22, and in models of dry skin and allergic 
contact dermatitis [70]. Histamine-induced scratching was reduced to a lesser extent, likely due 
to the remaining histamine-specific subpopulation (Fig 1A). These studies suggest that the 
MrgprA3-positive population of chloroquine-responsive neurons may be particularly tuned for 
sensing itch.  
 
Intracellular mediators of itch 
The majority of recently identified pruritogen receptors are Gq protein-coupled receptors 
(GqPCRs), which exert their physiological effects via protein kinase C (PKC) activation and 
release of intracellular calcium stores [63, 64, 71]. The specific signaling cascades immediately 
downstream of pruritogen receptor activation remain less clear. Sensory neuron activation via 
H1R appears to be dependent on PLCβ3, as demonstrated by the findings that PLCβ3 knock-out 
mice scratch less when injected with histamine and almost all DRG calcium responses to 
histamine are ablated [43]. However, this study also found that over 85% of IB4-positive neurons 
and more than 30% of peptidergic neurons expressed PLCβ3, posing the question of what 
mechanisms confer specificity to histaminergic signaling.  
The canonical PLC pathway generates inositol triphosphate (IP3) and diacylglycerol 
(DAG), which act to release intracellular calcium stores and activate downstream targets, 
respectively. Gq protein-coupled receptors induce PKC activation via the generation of DAG and 
release of intracellular calcium stores [72]. Several PKC isoforms are expressed in sensory 
neurons [73-75] and are known to directly modulate ion channels, pointing to one possible mode 
of regulation of itch signaling [75-77]. The novel PKC subtype PKCδ depends on DAG for 
activation and is found in sensory neurons [72, 73, 78, 79]. PKCδ does not play an important role 
in acute pain behavior but was demonstrated to be involved in CFA-induced thermal hyperalgesia 
- a TRPV1-dependent process [80]. Furthermore, studies of histamine-induced signaling in 
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human aortic endothelial cells (HAECs) and HeLa cells (all of which express H1R endogenously) 
demonstrate that PKCδ is phosphorylated in response to histamine [81, 82]. PKCδ also appears 
to be important for histamine-induced H1R mRNA up-regulation and activation of ERK1/2 and 
p38 [81, 82].  In chapter 2, we investigate whether PKCδ plays a role in the signaling of 
histaminergic and histamine-independent itch.  
Several studies indicate that pruritogen receptors are functionally linked to specific 
transient receptor potential (TRP) channels, a family of non-selective cation channels that can be 
activated by diverse environmental and physiological stimuli [83-87].  Early microneurography 
studies in humans demonstrate that most histamine-sensitive fibers respond to heat, suggesting 
the expression of the heat-sensitive channel TRPV1 [17, 19]. In vitro animal studies confirmed 
this, demonstrating that 30-60% of histamine-responsive sensory neurons can also be activated 
by the TRPV1 agonist capsaicin [47, 68, 86, 88]. TRPV1 deletion and pharmacological inhibition 
significantly reduced histamine-evoked scratching and sensory neuron responses to histamine, 
indicating a functional link between histamine receptor and TRPV1 [88, 89]. TRPV1 is also 
expressed in other subsets of pruriceptors, including MrgprA3- and MrgprC11-positive neurons, 
but it does not appear to play a functional role in histamine-independent itch [47, 48, 68, 86, 89, 
90]. 
Several findings indicate that histamine-independent itch is instead mediated by TRPA1, 
a promiscuous TRP channel activated by a number of environmental irritants. The TRPA1 agonist 
mustard oil (MO) activates a large proportion of CQ- and BAM8-22-responsive neurons [68, 86, 
90]. Both genetic deletion and pharmacological inhibition of TRPA1 significantly reduced 
scratching responses and neuronal activation by chloroquine and BAM8-22 [90, 91]. Interestingly, 
it appears that the Mrgpr receptors engage different mechanisms to activate TRPA1, where 
MrgprA3 signals via Gβγ, while MrgprC11 signals through PLC [90]. TRPA1 also mediates chronic 
itch and oxidative stress-induced itch, further demonstrating its role in histamine-independent 
mechanisms of pruritus [90, 92, 93].  
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Differentiating between itch and pain 
Itch and pain are two distinct sensory experiences. The prototypical behavioral response 
that inhibits itch is a noxious stimulus in the form of a scratch. Conversely, inhibition of pain by 
epidural anesthetics is frequently associated with itch. The polymodal nature of pruriceptive 
neurons has given rise to two major competing theories regarding the physiological basis of itch. 
The first, known as “the intensity theory”, postulates that itch arises from the same population of 
neurons that signal pain. It hypothesizes that stimulus intensity determines whether a stimulus is 
perceived as “itchy” or painful, with the expectation that a low-intensity noxious stimulus produces 
itch. The alternative, “labeled-line theory” proposes that itch- and pain-sensitive pathways are 
anatomically separate and specialized for transducing only one sensation.  
Recent studies of the molecular mechanisms that mediate itch and pain have uncovered 
evidence to support the labeled-line theory. Even though pruriceptors resemble nociceptors in 
their ability to respond to painful stimuli like heat and chemical irritants, a recent finding 
demonstrates that selective activation of pruriceptive neurons results in itch, not pain. In an 
elegantly designed study, Han et al. used TRPV1 global knock-out mice engineered to express 
TRPV1 solely in the MrgprA3-positive subset of neurons.  In these animals, cheek application of 
the TRPV1 agonist capsaicin induced itch-specific scratching instead of the nociceptive wiping 
response induced by capsaicin in wild type controls [70]. These results demonstrate that the 
selective activation of MrgprA3-positive neurons specifically transduces itch and further support 
the idea that pruriceptors are a distinct subset of sensory neurons specialized for sensing itch. 
Even so, psychophysical studies in humans have demonstrated that the sensation experienced 
after application of the pruritogens histamine, BAM8-22, or β-alanine may not be a true pure itch, 
as participants report it is frequently accompanied by prickling or burning undertones, suggesting 
more complex underlying mechanisms.   
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Development and sensitization of pruriceptors 
Primary afferents are pseudounipolar neurons derived from neural crest cells that migrate 
out of the neural tube and differentiate into a heterogeneous pool of proprioceptors, 
mechanoreceptors, thermoreceptors, nociceptors, and pruriceptors [94, 95]. The survival and 
phenotype specification of these functionally distinct groups is regulated by transcription factors 
and neurotrophic factors. Nerve growth factor (NGF) signals via the receptor tyrosine kinase A 
(TrkA) to support the survival of small diameter sensory neurons during embryogenesis  [96-103]. 
Those neurons which retain TrkA expression into adulthood become the peptidergic subset 
known for their expression of calcitonin gene-related peptide (CGRP) and substance P [100, 104, 
105]. However, about half of small diameter neurons downregulate TrkA in the early post-natal 
period and begin to express the receptor tyrosine kinase Ret [104, 106]. This subset is dependent 
on the glial cell line-derived neurotrophic factor (GDNF) family ligands (GFLs) GDNF, neurturin 
(NRTN), and artemin (ARTN). Ret activation by the GFLs requires a cell surface co-receptor 
known as GDNF Family Receptor α (GFRα). Analysis of GFL and co-receptor null mice 
demonstrates highly restricted physiological pairing of ligand and high affinity co-receptors in vivo: 
GFRα1/GDNF, GFRα2/NRTN, and GFRα3/ARTN [107, 108]. The small diameter Ret-positive 
neurons constitute the non-peptidergic subset of nociceptors, which are largely identified by their 
ability to bind the plant lectin isolectin B4 (IB4). Additionally, neurotrophic factor signaling via TrkA 
and Ret is necessary for the establishment of peripheral target innervation during development 
and the maintenance of innervation throughout adulthood [101, 109, 110]. The expression of TrkA 
and Ret determine neuronal dependence on different neurotrophic factors, contributing to the 
development and maintenance of anatomically and functionally distinct populations of sensory 
neurons.  
Sensory nerve fibers in the skin are in close proximity to keratinocytes, dermal fibroblasts, 
and immune cells, which can release pruritogens, various pro-inflammatory mediators, and 
neurotrophic factors (NTFs) [1, 111-119]. Studies have identified multiple mechanisms by which 
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inflammation and growth factors directly activate and sensitize nociceptors in the context of pain. 
NGF and the GFLs have been shown to directly sensitize and upregulate the expression of 
TRPV1 and TRPA1 [120-125]. Overexpression of select growth factors in keratinocytes results in 
epidermal hyperinnervation, sensory neuron cell body hypertrophy, and enhanced expression of 
TRP channels, which contributes to a state of hyperalgesia [126-130]. In addition, neurotrophic 
factors regulate the expression and function of sodium channels, which directly contribute to the 
regulation of nociceptor excitability [131-135]. In conclusion, these findings indicate a clear role 
for neurotrophic factors in the sensitization of pain, but whether and how they directly affect 
pruriceptors remains unknown. 
 Several key observations suggest that neurotrophic factors could contribute to chronic 
itch. First, epidermal hyperplasia and inflammatory cell infiltration are hallmarks of many pruritic 
skin diseases, serving as a source of increased neurotrophic factor levels. Studies of atopic 
dermatitis and psoriasis have shown that the severity of itching correlates with increased serum 
levels of NGF [136-139]. Lesional skin from atopic dermatitis patients is marked by increased 
levels of NGF in the skin and increased TrkA in epidermal nerve fibers [137-140]. Another recent 
study found that artemin is also increased in the skin of patients with atopic dermatitis [141]. 
Epidermal hyperinnervation of lesional skin is another common feature of pruritic skin diseases 
that suggests neurotrophic factor involvement [140, 142, 143]. Co-culturing human keratinocytes 
from patients with atopic dermatitis with porcine sensory neurons resulted in increased local NGF 
release and greater axon growth when compared to a co-culture using healthy human 
keratinocytes [144]. NGF and TrkA inhibition in a mouse model of atopic dermatitis reduced both 
scratching and epidermal fiber density [145, 146]. Human TrkA deficiency results in congenital 
insensitivity to both pain and itch, confirming that NGF-TrkA signaling plays a key role in the 
development and maintenance of pruriceptors [147]. 
Acutely, intradermal injection of NGF in human subjects enhanced itch produced by the 
non-histaminergic pruritogen cowhage [148]. In a Phase II clinical study investigating artemin as 
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a potential treatment for unilateral sciatica, the most commonly reported adverse reactions to 
intravenous or subcutaneous artemin administration were changes in temperature perception and 
pruritus [149, 150]. In animal studies, artemin treatment induced warmth-provoked scratching 
behavior that was dependent on the expression of the artemin co-receptor GFRα3 [141]. Finally, 
neurotrophic factors can directly induce mast cell degranulation, stimulating local histamine 
release to induce itch [151-154]. These findings suggest that NTFs regulate itch, but the 
mechanisms of this modulation are poorly understood.    
Immunohistochemical characterization of pruriceptive neurons suggests a potential role 
for both NGF-TrkA and GFL-Ret signaling in the regulation of pruriceptor physiolgy. Histamine-
responsive neurons co-express TRPV1 and their activation results in the axon-reflex vasogenic 
reaction, suggesting they express peptides, likely making them TrkA-positive. On the other hand, 
Ret is expressed in both the β-alanine- and chloroquine-responsive subsets of pruriceptive 
neurons (Fig 1B-C) [58, 70]. Interestingly, the MrgprA3-positive group was also found to express 
CGRP, indicating that MrgprA3 pruriceptors represent a small subpopulation of neurons that have 
retained both peptidergic and non-peptidergic markers [70]. In chapter 4 of this manuscript, we 
investigate the role of both NGF and the GFLs GDNF, neurturin, and artemin in histamine- and 
chloroquine-evoked itch.  
 
Translational approaches to preclinical studies of itch and pain 
For decades, animal models have been the backbone of preclinical research. Studies 
using mice provide key advantages, most notably precise genetic manipulation and quick 
breeding, that allow thorough hypothesis testing in a complex biological system. As an in vitro 
model, primary cultures of dissociated rodent sensory neurons have been used to study pain, 
itch, nerve injury, regeneration, and axonal transport. Many candidate molecular targets and 
genes have been identified using this approach, yet few of these findings have directly translated 
into effective and safe clinical treatments [155-159]. Several notable failures in translation suggest 
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prominent differences in fundamental biological mechanisms between humans and rodents [160-
166]. MrgprA3 and MrgprC11 pruriceptor physiology is one important example of fundamental 
receptor differences between species. Due to divergent evolutionary mechanisms, these receptor 
families are greatly expanded in the mouse, but are not found in primates.  While the human 
MRGPRX1 receptor can be activated by the same agonists, key differences in receptor structure 
and pharmacology demonstrate that these receptors are not true orthologs [47, 48, 70, 167]. In 
addition, the functional link between mouse MrgprA3 and C11 receptors and TRPA1 may not be 
present in primates. Studies using heterologous expression models suggest that MRGPRX1 may 
actually engage TRPV1 as a downstream mechanism for cell activation [167, 168]. Thus, key 
differences in the molecular mechanisms underlying human and rodent sensory neuron 
processing demonstrate the importance of preclinical target validation in human cells [169-172].  
A major obstacle impeding the validation of basic research findings is access to human 
tissues. Human neurons are notoriously difficult to obtain and maintain in culture for use in 
experiments. That is most likely the reason why very little is currently known about the physiology 
of human pruriceptive subpopulations. In the final study in this dissertation, we describe a protocol 
we developed for the surgical extraction of human dorsal root ganglia from deceased organ 
donors. This approach has provided us with access to human tissue with a minimal post-mortem 
interval, allowing the successful culturing of human sensory neurons. In chapter 5, we 
characterize the human pruriceptive subpopulations that respond to histamine and chloroquine, 
and directly test the effects of neurotrophic factors on pruriceptor calcium responses.  
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Abstract 
 
Itch-producing compounds stimulate receptors expressed on small diameter fibers that 
innervate the skin. Many of the currently known pruritogen receptors are Gq-Protein Coupled 
Receptors (GqPCR), which activate Protein Kinase C (PKC). Specific isoforms of PKC have been 
previously shown to perform selective functions; however, the roles of PKC isoforms in regulating 
itch remain unclear. In this study, we investigated the novel PKC isoform PKCδ as an intracellular 
modulator of itch signaling in response to histamine and the non-histaminergic pruritogens 
chloroquine and β-alanine. Behavioral experiments indicate that PKCδ knock-out (KO) mice have 
a 40% reduction in histamine-induced scratching when compared to their wild type littermates. 
On the other hand, there were no differences between the two groups in scratching induced by 
the MRGPR agonists chloroquine or β-alanine. PKCδ was present in small diameter dorsal root 
ganglion (DRG) neurons. Of PKCδ-expressing neurons, 55% also stained for the non-peptidergic 
marker IB4, while a smaller percentage (15%) expressed the peptidergic marker CGRP. Twenty-
nine percent of PKCδ-expressing neurons also expressed TRPV1. Calcium imaging studies of 
acutely dissociated DRG neurons from PKCδ-KO mice show a 40% reduction in the total number 
of neurons responsive to histamine. In contrast, there was no difference in the number of 
capsaicin-responsive neurons between KO and WT animals. Acute pharmacological inhibition of 
PKCδ with an isoform-specific peptide inhibitor (δV1-1) also significantly reduced the number of 
histamine-responsive sensory neurons. Our findings indicate that PKCδ plays a role in mediating 
histamine-induced itch, but may be dispensable for chloroquine- and β-alanine-induced itch.    
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Introduction 
Itch, clinically known as pruritus, is an unpleasant sensory and emotional experience that 
leads to the desire to scratch [1, 2]. Chronic itch can result in severe anxiety, self-mutilation, and 
impaired overall quality of life that is comparable to chronic pain [3-5]. Several histamine-
dependent and histamine-independent itch receptors have been recently identified; however, few 
of the intracellular mediators downstream of these receptors have been characterized. Elucidating 
the intracellular mediators that activate pruriceptors may provide a new set of targets to aid in the 
generation of more specific and efficacious treatments.  
Intradermal histamine induces itch via direct activation of the H1 histamine receptor, which 
is expressed in sensory neurons [6-10]. Additionally, several subtypes of the recently 
characterized class of Mas-related gene protein receptors (Mrgpr) have been shown to respond 
selectively to a variety of non-histaminergic, itch-producing compounds. For example, MrgprA3 is 
activated by the anti-malarial drug chloroquine (CQ) [11, 12], and β-alanine induces itch by 
activating a subset of nonpeptidergic MrgprD-expressing sensory neurons [13, 14].  
A common property of many of the identified pruritogen receptors, including the H1 
histamine receptor (H1R), MrgprA3, and MrgprD, is that they are Gq-protein coupled receptors 
(GqPCRs) [10-12, 14]. Canonically, GqPCRs activate phospholipase C (PLC), which cleaves 
phosphatidylinositol (PIP2) into inositoltriphosphate (IP3) and diacylglycerol (DAG), resulting in 
release of intracellular calcium stores and activation of downstream targets. However, the itch-
mediating factors downstream of PLC are largely unknown [10, 15]. Protein kinase C (PKC) is 
coupled to the canonical GqPCR/PLC pathway via activation by DAG and/or calcium and therefore 
may play a role in the signaling of itch.  
A number of PKC isoforms are expressed in sensory neurons [16-19]. One of these 
isoforms is PKCδ, a member of the “novel” PKC isozymes, which depends on DAG but not 
calcium for its activation. Previously, we demonstrated that PKCδ is dispensable for withdrawal 
responses to acute noxious mechanical and thermal stimuli [20]. However, studies of H1R 
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signaling in human aortic endothelial cells and HeLa cells showed that PKCδ is phosphorylated 
in response to histamine [21, 22]. PKCδ also mediated histamine-induced H1R mRNA 
upregulation and downstream activation of ERK1/2 and p38 [21, 22]. These lines of evidence 
suggest that PKCδ could play a specific role as an intracellular modulator of itch in sensory 
neurons.  
In this study, we tested the hypothesis that PKCδ contributes to pruritogen-induced itch. 
We determined the role of PKCδ in histaminergic and non-histaminergic itch by examining 
scratching responses to histamine and the non-histaminergic pruritogens chloroquine and β-
alanine, which activate separate pruriceptor subpopulations. We characterized the distribution of 
PKCδ in sensory neurons and show that both genetic deletion and pharmacological inhibition of 
PKCδ significantly decrease the proportion of histamine-responsive neurons.  
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Materials and Methods 
Subjects and ethical approval 
All experiments were conducted in accordance with the National Institute of Health guidelines 
and received the approval of the Animal Care and Use Committee of Washington University 
School of Medicine. Eight to twelve-week old male littermate mice were housed on a 12 hour light-
dark cycle and allowed ad libitum access to food and water. 
PKCδ-KO mice were obtained from Dr. Michael Leitges [23]. These mice were generated 
using a standard gene targeting approach to insert a LacZ/neo cassette in the first transcribed 
exon of the PKCδ gene to abolish transcription, resulting in a global knock-out [23]. PKCδ-KO 
mice were backcrossed on a C57BL/6 background for at least 6 generations prior to use. PKCδ-
KO mice were then crossed with wild type C57BL/6 mice to generate heterozygous mice, which 
were used to generate wild type and KO littermates.  
 
Pruritogen-induced scratching behavior 
The nape of the neck and upper back were shaved with electric clippers one day prior to 
behavioral experiments. On the day of experiment, mice were placed in individual plexiglass 
observation boxes and allowed to acclimate in the presence of white noise for 2 hours. Using 
gentle restraint, 50μl consisting of pruritogen dissolved in 0.9% normal saline was injected 
intradermally at the nape of the neck using a 29½ gauge insulin syringe. The following pruritogen 
amounts were used: 1mg histamine (Sigma Aldrich, St. Louis, MO), 200μg chloroquine (Sigma 
Aldrich, St. Louis, MO), and 223μg β-alanine (Sigma Aldrich, St. Louis, MO). A single scratch bout 
was defined as one or more rapid back-and-forth motions of the hindpaw directed at the injection 
site, ending with either a pause, licking, or biting of the toes or placing of the hindpaw on the floor. 
Scratch bouts by the hind-paw directed at the injection site were counted over a period of 30 
minutes. Experimenters were blinded to mouse genotype.  
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PKCδ immunohistochemistry and Western Blotting  
For Western blotting, mice were euthanized by swift decapitation and lumbar spinal cord and 
lumbar DRG were removed. Tissue samples were homogenized in homogenization buffer (20mM 
Tris-HCl, ph7.4, 1mM EDTA, 1mM sodium pyrophosphate, 25μg/ml aprotinin, 25μg/ml leupeptin 
and 100μM phenylmethylsufonyl fluoride) on ice. 7μg of spinal cord and DRG protein were 
separated using 4-12% SDS-PAGE, then transferred to nitrocellulose membrane. Membrane was 
blocked in Odyssey blocking buffer for 1 hour, then incubated in rabbit anti-PKCδ (1:1000, Santa 
Cruz) and mouse anti-β-Tubulin (1:1000, Sigma-Aldrich) primary antibodies in Odyssey buffer 
with 0.1% Tween-20 at 4°C overnight. Blots were then washed in TBS-0.1% Tween-20, and 
incubated for 1 hour at room temperature in secondary antibodies (goat anti-rabbit Alexa Fluor 
680 (1:20,000, Sigma Aldrich); goat anti-mouse IR800 (1:20,000, Sigma Aldrich)). Blots were 
washed and scanned using an Odyssey infrared scanner.     
For immunohistochemistry (IHC), mice were deeply anesthetized with a ketamine, xylazine, 
and acepromazine cocktail, then perfused intracardially with cold PBS followed by 4% 
paraformaldehyde in PBS. Lumbar DRG were removed and cryoprotected in 30% sucrose. 
Transverse sections were cut at 18μm thickness on a cryostat and collected on slides. To 
determine the percentage of total neurons that express PKCδ, dual labeling was performed with 
rabbit anti-PKCδ (1:50, Santa Cruz) and mouse anti-β-tubulin (1:1000, Sigma Aldrich) primary 
antibodies. Briefly, sections were blocked in 2% BSA, 0.1% Milk powder, 0.05% Tween-20 TBS 
for 1 hr, then incubated in primary antibodies overnight at 4°C. On day 2, slides were washed and 
incubated in secondary antibodies for 2-4 hours at 4°C (Alexa Fluor 488 Donkey anti-rabbit 1:200, 
Alexa Fluor 555 donkey anti-mouse 1:200, Invitrogen). Images were obtained using an upright 
epifluorescent microscope (Nikon 80i, CoolSnapES camera). Labeled neurons were counted in 
at least 3 randomly selected sections separated by >50μm per animal. The size distribution of 
PKCδ+ neurons was determined using ImageJ software to measure cell diameter. The 
percentage of PKCδ+ neurons that also expressed CGRP or IB4 was determined using dual 
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labeling for PKCδ and CGRP (goat anti-CGRP 1:400, Serotec) or Alexa-568 conjugated to IB4 
(1:400, Invitrogen) using the above-described procedures. PKCδ-TRPV1 coexpression was 
determined using a goat anti-PKCδ antibody (1:50, Santa Cruz) and a rabbit antibody directed 
against the TRPV1 C-terminus peptide (1:500) [24].   
 
Calcium imaging 
Scratching behavior was evoked with pruritic stimuli applied to the back skin where site 
directed scratching occurs. We expanded our functional analyses of neuronal physiology to 
include both thoracic and lumbar DRG. Mice were euthanized rapidly by decapitation and DRG 
removed and acutely dissociated using previously described methods [25].  Briefly, DRG were 
incubated in 45U papain/L-cysteine in Hank’s buffered saline solution (HBSS) without Ca2+ or 
Mg2+ and with 10mM HEPES for 20 minutes at 37°C and 5% CO2. Ganglia were then washed, 
followed by 20 minute incubation in 1.5 mg/ml collagenase in HBSS+HEPES. Ganglia were then 
triturated with fire-polished Pasteur pipettes, the dissociated cells were filtered through a 40 μm 
cell strainer, and were plated on poly-D-lysine and collagen-coated glass coverslips. Cells were 
incubated overnight at 37°C in 5% CO2 humidified air in culture medium (Neurobasal A with B27, 
pen/strep, 2mM glutamax, 5% fetal bovine serum (Gibco)). All experiments were performed within 
24 hours of plating.  
Cells were incubated in 3μg/ml Fura-2 AM (Molecular Probes) for 30 minutes and then 
incubated for 30 minutes in external solution (in mM): 130 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 30 
Glucose, 10 HEPES. For each recording, a coverslip was placed in a perfusion chamber and 
perfused with external solution at room temperature. Cells were viewed under an inverted 
microscope (Olympus Optical, Tokyo, Japan) and images were captured with a Hamamatsu Orca 
camera. SimplePCI Software was used to draw regions of interest (ROI) around Fura-loaded cells 
prior to recording. The ratio of fluorescence emission at an excitation wavelength of 357 and 
380nm was measured for each ROI. The experimental protocol consisted of a 2 minute baseline 
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followed by 30 second bath application of histamine (100μM in external solution), >8 minutes of 
external solution wash, 10 second application of capsaicin (200nM), >8 minutes of external 
solution wash, and 10 seconds of KCl (50mM) followed by wash (<2 minutes) to determine live 
neurons. A 10% or greater change from baseline 357nm/380nm ratio was considered a response 
to histamine. Capsaicin experiments were performed similarly except with 10 second capsaicin 
application (200nM). For experiments using PKCδ peptide inhibitor and scrambled peptide, cells 
were incubated in 100μM peptide solution (dissolved in external solution) for 30 minutes prior to 
recording (δV1-1 peptide inhibitor (Myr-SFNSYELGSL-NH2), peptide inhibitor scramble (Myr-
GLSFSEYLSN-NH2), Biomatik).  
 
List of abbreviations 
PKC: protein kinase C; GqPCR: Gq protein-coupled receptor; MRGPR: Mas-related gene protein 
coupled receptor; CQ: chloroquine; KO: knock-out; WT: wild type; DRG: dorsal root ganglion; SC: 
spinal cord; PLC: phospholipase C; PIP2: phosphatidylinositol; IP3: inositoltriphosphate; DAG: 
diacylglycerol; H1R: histamine receptor 1; ERK1/2: extracellular signal regulated kinase 1/2; 
CGRP: calcitonin gene-related peptide; IB4: isolectin B4; Scr: scramble; Inh: inhibitor; PBS: 
phosphate-buffered saline; HBSS: Hank’s buffered saline solution; IHC: immunohistochemistry; 
TRPV1: transient receptor potential vanilloid receptor 1; TRPA1: transient receptor potential 
cation channel, subfamily A, member 1; PGE2: prostaglandin E2; NGF: nerve growth factor; IL-6: 
interleukin-6 
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Results 
PKCδ mediates histamine-induced itch 
To determine if PKCδ plays a role in behavioral responses to itch, we assessed scratching 
responses to histamine and non-histaminergic pruritogens in PKCδ knock-out mice (PKCδ-KO) 
and their wild type littermates. Mice were injected intradermally at the nape of the neck with one 
of three pruritogens: histamine (1mg), chloroquine (CQ) (200μg), or β-alanine (223μg). PKCδ-KO 
mice scratched significantly less than their wild type littermates when injected with histamine 
(Figure 1A, p<0.05). On the other hand, chloroquine-induced scratching was not significantly 
different between WT and PKCδ KO mice (Figure 1B, p=0.129). There was also no difference in 
the number of scratch bouts induced by β-alanine (Figure 1C, p=0.61). These results indicate that 
PKCδ mediates histaminergic itch, but is not necessary for non-histaminergic itch induced by CQ 
and β-alanine.  
 
 
Figure 1. PKCδ-KO and WT scratching responses to pruritogens. A. PKCδ-KO mice 
scratched less than wild type littermates in response to intradermal histamine injection 
(WT=121.4±12.8 scratch bouts/30min, n=25; KO=73.8±15.5 scratch bouts/30min, n=19; 
unpaired t test p<0.05). B. Chloroquine (CQ)-induced scratching was not different between 
PKCδ-KO and WT mice (WT=163.7±22.6 scratch bouts/30min, n=23; KO=118.0±18.9 scratch 
bouts/30min, n=21; unpaired t test p=0.129). C. Scratch bouts induced by β-alanine were also 
not different between PKCδ-KO and WT mice (WT=57.0±10 scratch bouts/30min, n=6; 
KO=48.8±12.3 scratch bouts/30min, n=8; unpaired t test p=0.61). 
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PKCδ is preferentially expressed in small diameter DRG neurons 
PKCδ is expressed in a variety of tissues, including the brain and peripheral nervous 
system [19, 21, 26-33]. To assess whether PKCδ is localized to potential pruriceptive sensory 
neurons, immunohistochemistry (IHC) was used to characterize the distribution of PKCδ in dorsal 
root ganglion (DRG) neurons. Antibody specificity was confirmed via western blot using PKCδ-
KO DRG and spinal cord tissue. No antibody staining was found corresponding to the 78kD PKCδ 
band in PKCδ-KO DRG tissue (Figure 2A). This was further confirmed by IHC of knock-out and 
wild type DRG (Figure 2B). In wild type lumbar DRG, PKCδ was expressed in 43.2% of total 
neurons labeled with βIII tubulin (567/1314 cells, n=3 animals) and PKCδ expression was 
 
Figure 2. Immunological analyses of PKCδ in the spinal cord and DRG. A. Western blot 
demonstrating expression of PKCδ in WT DRG and spinal cord (SC) but not in PKCδ-KO tissue 
confirming the validity of the PKCδ antibody. B. Representative images of 18μm sections from 
WT and PKCδ-KO lumbar DRG. (Scale bar = 50μm) C. Histogram of cell diameter 
measurements of PKCδ+ and PKCδ- neurons illustrates the localization of PKCδ to small and 
medium diameter soma.  
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predominantly restricted to small diameter neurons (average diameter 23.3±0.19μm, min 11.6μm, 
max 36.2μm) (Figure 2C). 
 
PKCδ is expressed in peptidergic and non-peptidergic DRG neurons 
We further characterized PKCδ expression in small diameter DRG neurons by 
immunohistochemical analysis of peptidergic and non-peptidergic markers. Of peptidergic 
neurons identified by anti-Calcitonin Gene Related Peptide (CGRP+) immunoreactivity, 26.8% 
expressed PKCδ, while 14.7% of PKCδ-expressing neurons were CGRP-positive (Table 1, Figure 
3A-B). PKCδ was also expressed in non-peptidergic neurons identified by isolectin B4 (IB4) 
binding. Of IB4+ DRG neurons, 61.6% expressed PKCδ and 55.0% of PKCδ+ neurons exhibited 
IB4 binding (Table 1, Figure 3C-D). These findings indicate that PKCδ is expressed in both 
 
Figure 3. Localization of PKCδ and markers of peptidergic and non-peptidergic dorsal 
root ganglion neurons. A. Representative images of CGRP+, PKCδ+, and co-expressing 
(Merge) DRG neurons. B. Graphical representation of total neurons counted and degree of 
overlap (n = number of neurons). C, D. Representative images of IB4+, PKCδ+, and 
IB4+/PKCδ+ neurons and illustration of overlap.  E, F. Representative images of TRPV1+, 
PKCδ+, and TRPV+/PKCδ+ neurons and illustration of overlap. Inset demonstrates TRPV1 
antibody stain in TRPV1-KO mice. (Scale bar = 50μm; Arrowheads indicate example cells that 
express both markers). 
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peptidergic and non-peptidergic sensory neurons, with greater expression overlap found with non-
peptidergic IB4+ neurons. 
Behavioral and physiological studies have shown that itch produced by histamine is largely 
dependent on the non-specific cation channel transient receptor potential vanilloid receptor 1 
(TRPV1) [34-36]. Because PKC has previously been demonstrated to modulate TRPV1 function 
and may present one potential mechanism by which PKCδ regulates itch, we determined the 
degree of overlap between PKCδ and TRPV1 expression [24, 37]. We first confirmed the 
specificity of our antibody directed against TRPV1 using TRPV1 knockout mice (Figure 3E, inset). 
Our data indicate that 29.1% of PKCδ-positive neurons were also TRPV1-positive, and 48.9% of 
TRPV1-positive neurons also expressed PKCδ, suggesting a potential functional relationship 
between PKCδ and TRPV1 (Figure 3E-F; Table 1).  
Table 1. Percent of DRG neurons in which PKCδ colocalizes with other markers (mean ± 
SEM). (n = 3-4 mice per marker.)  
 
 
Marker 
% of PKCδ+ neurons 
expressing marker 
% of marker+ neurons 
expressing PKCδ 
CGRP 14.7 ± 2.5 26.8 ± 3.5 
IB4 55.0 ± 3.0 61.6 ± 7.9 
TRPV1 29.1 ± 2.2 48.9 ± 4.0 
 
PKCδ-KO sensory neurons exhibit diminished responses to histamine 
PKCδ is expressed in the brain, spinal cord, and the peripheral nervous system [33, 38-
41]. Therefore, global genetic deletion of PKCδ in our knockout mice makes it difficult to pinpoint 
where PKCδ functions to modulate histamine-induced scratching. The expression of PKCδ in 
small diameter sensory neurons suggests that it may mediate histamine-evoked itch by signaling 
in nociceptive neurons responsive to pruritic agents (i.e., pruriceptors). To determine if PKCδ 
directly modulates neuronal responses to histamine, calcium imaging was performed on acutely 
dissociated adult mouse DRG neurons (Figure 4A-B). Of the total sensory neurons treated with 
histamine, 11.1% of wild type neurons responded to bath application of 100μM histamine 
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(126/1137 total WT neurons, N=5 animals), but only 6.7% of PKCδ-KO neurons responded to 
histamine (47/706 total KO neurons, N=3 animals), indicating a significant reduction of 39.6% in 
the proportion of histamine responsive neurons (p<0.01, χ2 test) (Figure 4C). No significant 
difference in peak calcium responses to histamine was detected between knock-out and wild type 
cells (WT 33.6±2.8% increase from baseline, n=126 cells; KO 39.9±6.6% increase from baseline, 
n=47 cells, unpaired t-test, p=0.304) (Figure 4D).  
We hypothesized that PKCδ could contribute to neuronal responses to histamine by 
mediating histamine receptor coupling to TRPV1, or by regulating the normal expression or 
function of TRPV1. To investigate whether the absence of PKCδ affects the activation of TRPV1 
within histamine-responsive neurons, we applied the TRPV1-specific agonist capsaicin after the 
histamine response. We found that 58.7% of WT histamine-responsive neurons subsequently 
responded to capsaicin (74/126 total His+ neurons), while only 40.4% of KO histamine-sensitive 
neurons responded to capsaicin (19/47 total His+ neurons; p<0.05, χ2 test) (Figure 4E). To 
determine whether the functional expression of TRPV1 is altered in PKCδ-KO neurons, we tested 
WT and KO sensory neurons for responses to capsaicin. There were no differences in the total 
number of capsaicin-responsive neurons between KO and WT groups (117/194 (60.3%) WT 
neurons, 144/259 (55.6%) KO neurons, p=0.315, χ2 test, Figure 4G). Together, these data 
indicate that the reduction in histamine responses is not due to altered levels of TRPV1 receptors 
in the KO, and support the idea that PKCδ could modulate TRPV1 downstream of histamine 
receptor activation.  
To further control for the possibility of developmental effects or compensatory 
mechanisms that may occur with congenital genetic deletion of PKCδ, we performed calcium 
imaging experiments with the same experimental design using acute pharmacological inhibition 
in wild type DRG cultures. The δV1-1 peptide inhibitor has been shown to inhibit PKCδ activation 
in vitro and in vivo by competitively binding to receptor for activated C-kinase (RACK) 
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Figure 4. PKCδ mediates sensory neuron responses to histamine. A. Representative 
image of dissociated DRG neurons loaded with Fura2-AM. B. Representative traces of 
selected cells (corresponding colored circles in A) in response to histamine, capsaicin, and 
KCl. C. Proportion of total histamine responders in WT and KO DRG neurons (WT=11.1% 
(126/1137 total WT neurons); KO=6.7% (47/706 total KO neurons); ** p<0.01, χ2 test). D. Peak 
calcium increase in response to histamine, defined as % signal increase above baseline. WT 
33.6±2.8% change from baseline, n=126 cells; KO 39.9±6.6% change from baseline, n=47 
cells, unpaired t-test, p=0.304. E. Percent of histamine-responsive neurons that responded to 
capsaicin (74/126 WT His+ neurons; 19/47 KO His+ neurons; p<0.05, χ2 test). F. Proportion of 
capsaicin-responsive neurons (117/194 WT neurons, 144/259 KO neurons, p=0.315, χ2 test). 
G. Proportion of histamine-responsive neurons in scramble- vs. inhibitor-treated groups 
(18.5% (75/405) of scramble-treated neurons vs. 13.1% (69/527) of peptide-treated neurons, 
p<0.05, χ2 test). H. Peak calcium increase in response to histamine (inhibitor: 33.23±2.7% 
change from baseline, n=69 cells; scramble: 41.0±3.7% change from baseline, n=75 cells, 
p=0.095, unpaired t test). 
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proteins, which confer PKC isoform substrate specificity [31, 42-45]. DRG neurons were 
incubated with the peptide inhibitor δV1-1 for 30 minutes prior to recording. Consistent with our 
findings in PKCδ-KO neurons, there was a significant reduction in the total number of histamine-
responsive neurons treated with peptide inhibitor when compared to scramble peptide-treated 
control neurons (18.5% (75/405) of scramble-treated neurons vs. 13.1% (69/527) of peptide-
treated neurons, N=4 animals, p<0.05, χ2 test) (Figure 4F). Peak calcium responses induced by 
histamine were not different between inhibitor- and scramble-treated groups (inhibitor 33.23±2.7% 
change from baseline, n=69 cells; scramble 41.0±3.7% change from baseline, n=75 cells, 
p=0.095, unpaired t test) (Figure 4G).  
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Discussion 
Pruritic stimuli can activate sensory neurons via specific intracellular signaling cascades, 
which represent potential targets for anti-pruritics, but these cascades remain poorly understood. 
Characterizing signaling components is a significant challenge, in part because of the great 
diversity of recently identified pruritic receptors. Some receptors involved in pruritus are coupled 
to Gi/o cascades such as the H4 histamine receptor, while others utilize kinase signaling pathways 
like the TSLP/IL-7 receptors [6, 7, 46, 47]. However, the majority of identified pruritic receptors, 
including the H1 receptor and the “orphan” family of MRGPR receptors, are linked by a common 
Gαq signaling mechanism [10, 48-51]. In this study we focused on a component downstream of 
the canonical Gαq signaling pathway, the serine/threonine kinase PKC.  
PKC isozymes are divided into three groups: classic (activated by DAG and Ca2+), novel 
(activated by DAG but not Ca2+), and atypical (activated by neither DAG nor Ca2+) [52, 53]. 
Specific PKC isoforms have been shown to selectively regulate nociceptive behavior and 
nociceptor physiology [16, 17, 19, 54-60]. We previously showed that the novel isozyme PKCδ is 
dispensable for acute mechanical and thermal nociceptive behaviors [20].  Previous reports have 
implicated PKCδ in H1R signaling in non-neuronal cells [21, 22], but the specific role of PKCδ in 
pruriceptor signaling and itch had not been explored. In this study we found that PKCδ was 
necessary for the full expression of histamine-induced itch, but it did not have significant effects 
on histamine-independent itch produced by the MRGPR ligands chloroquine or β-alanine. 
To determine whether the scratching deficit we observed in PKCδ null mice could be 
attributed to loss of function within sensory neurons, we examined anti-PKCδ staining in mouse 
lumbar DRG. Previous studies indicated that PKCδ is expressed in murine spinal cord and DRG, 
but the precise subset of PKCδ-positive neurons had not been characterized [33, 38-41]. We 
found that PKCδ expression was restricted to small diameter dorsal root ganglion neurons. 
Furthermore, although PKCδ was expressed in both peptidergic and non-peptidergic sensory 
neurons, it was greatly enriched in the non-peptidergic subset. Both peptidergic and 
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nonpeptidergic fibers have been shown to play a role in pruritus. Histaminergic itch is largely 
dependent on CGRPα-positive neurons [61], however, a subset of histamine-responsive neurons 
also express the nonpeptidergic marker IB4 [11, 62].  
Calcium imaging studies of dissociated DRG neurons demonstrated that genetic deletion 
of PKCδ resulted in a significant reduction of the proportion of adult sensory neurons that were 
histamine-responsive. We further confirmed these results using acute pharmacological inhibition, 
supporting the hypothesis that PKCδ functions within normal wild type sensory neurons to 
mediate acute histaminergic signaling. The expression of PKCδ in small diameter sensory 
neurons, along with the reduction of histamine-responsive sensory neurons, suggest a peripheral 
mechanism for the behavioral effects of global PKCδ deletion on histamine-induced scratching.  
Following histamine release, sensory neuron signaling to produce itch is thought to 
depend on functional coupling of H1R to TRPV1. Supporting this idea, mice lacking TRPV1 exhibit 
greatly reduced scratching behavior and cellular responses to histamine, and blocking TRPV1 
channel function likewise abolishes the response of sensory neurons to histamine [34, 36, 63]. 
The mechanisms by which H1R recruits TRPV1 are complex and several different signaling 
pathways have been implicated [35, 36, 64, 65]. One possible mechanism by which histamine 
could couple to TRPV1 in sensory neurons is through PLC-induced PKC activation. This is further 
supported by an expanding body of literature indicating that PKC directly modulates TRPV1 
function [24, 37]. Indeed, inhibitors for PLC and PKC prevent histamine-induced TRPV1-
potentiation [64]. We previously found that acute mechanical and thermal pain were independent 
of PKCδ. In contrast, PKCδ was necessary for the full expression of thermal hyperalgesia during 
Complete Freund’s Adjuvant-induced inflammation, which is a TRPV1 dependent process [20].  
In this study, 49% of TRPV1-expressing neurons were PKCδ-positive and we showed a 
significant reduction in the proportion of capsaicin-responsive neurons within the subset of 
neurons responsive to histamine. Additionally, sensory neurons from PKCδ-KO mice not 
previously treated with histamine responded similarly to wild type neurons when challenged with 
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capsaicin. These observations indicate that acute detection of heat stimuli by TRPV1 is not 
dependent on PKCδ, but suggest that PKCδ could function downstream of the histamine receptor 
to modulate TRPV1 function. In further support of this idea, several other inflammatory mediators 
including PGE2, NGF, and IL-6 have been shown to activate PKCδ [41, 66-68]. It is possible that 
pruritic dermatoses marked by inflammation may recruit PKCδ, resulting in sensory neuron 
modulation that could potentiate itch. 
In contrast to histaminergic signaling, the MRGPR receptors appear to produce their 
pruritic effects through an alternative, PKCδ-independent pathway. Chloroquine activates 
MRGRPA3 which couples to the irritant receptor TRPA1 to produce itch. Neuronal responses to 
chloroquine were prevented by inhibiting Gβγ subunit activity, suggesting that the Gαq pathway is 
not necessary for chloroquine-induced itch [15]. However, MRGPRA3 was also recently shown 
to sensitize TRPV1 via a PKC mechanism likely dependent on Gαq signaling, suggesting a 
possible mechanism for thermal sensitization [69]. This suggests that MRGPRA3 may have 
biased signaling mechanisms that lead to itch and/or TRPV1-related sensitization. Thus, the 
histamine receptor and MRGPRs may share a pathway leading to sensitization of TRPV1 via PKC 
signaling, despite an alternative Gβγ mechanism for MRGPRA3 signaling of itch [48, 70]. 
In summary, we found that PKCδ is a mediator of histaminergic itch signaling in sensory 
neurons. Although we specifically investigated PKCδ in this study, other PKC isoforms may also 
be involved in modulating the response to itch. For example, another novel PKC isozyme, PKCε, 
is expressed in largely IB4+ neurons, and has been shown to also modulate TRPV1 responses 
[16, 59, 60, 71]. The sensory neuron responses involved in itch are complex, involving multiple 
molecular cascades which may be differentially mediated by specific PKC isoforms. Future 
studies that investigate the roles of PKC isozymes in itch may contribute to better therapeutic 
specificity for the treatment of acute and chronic pruritus.  
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Abstract 
Chronic pruritic conditions are often associated with dry skin and loss of epidermal barrier 
integrity. In this study, repeated application of acetone and ether, followed by water (AEW) to the 
cheek skin of mice produced persistent scratching behavior with no increase in pain-related 
forelimb wiping, indicating the generation of itch without pain. Cheek skin immunohistochemistry 
showed a 64.5% increase in total epidermal innervation in AEW-treated mice compared to water-
treated controls. This increase was independent of scratching, because mice prevented from 
scratching by Elizabethan collars showed similar hyperinnervation. To determine the effects of 
dry skin treatment on specific subsets of peripheral fibers, we examined Ret-positive, CGRP-
positive, and GFRα3-positive intraepidermal fiber density. AEW treatment increased Ret-positive 
fibers, but not CGRP-positive or GFRα3-positive fibers, suggesting that a specific subset of non-
peptidergic fibers could contribute to dry skin itch. To test whether trigeminal ganglion neurons 
innervating the cheek exhibited altered excitability after AEW treatment, primary cultures of 
retrogradely labeled neurons were examined using whole-cell patch clamp electrophysiology. 
AEW treatment produced no differences in measures of excitability compared to water-treated 
controls. In contrast, a significantly higher proportion of trigeminal ganglion neurons were 
responsive to the non-histaminergic pruritogen chloroquine after AEW treatment. We conclude 
that non-peptidergic, Ret-positive fibers and chloroquine-sensitive neurons may contribute to dry 
skin pruritus.  
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Introduction 
 Pruritus is a primary complaint associated with xerosis (dry skin) and other dermatoses 
that compromise skin barrier integrity such as atopic dermatitis and psoriasis [1, 2]. A rodent 
model of persistent and ongoing dry skin pruritus was previously developed by application of 
equal parts acetone and ether followed by water (AEW) to the rostral back skin [3]. Adaptation of 
the AEW model to the hind-limb, where biting and licking behaviors were used to indicate itch, 
showed an absence of behavioral sensitization to heat and mechanical stimuli, suggesting the 
dry skin produced itch but not hyperalgesia [4]. Recently, clear differentiation between pain and 
itch behaviors was achieved by application of algogens or pruritogens to the rodent cheek [5, 6]. 
When repeated AEW treatments were applied to the cheek, hind-limb scratching behavior was 
evoked, indicating that dry skin produced ongoing itch [7]. 
The mechanisms by which dry skin generates itch are unclear. Intriguingly, human pruritic 
dermatoses are frequently associated with increased intraepidermal fiber density [8-11]. 
Increased intraepidermal fiber density was also reported after a single, acute application of 
acetone in rodents [12, 13], and has been hypothesized to occur in AEW-induced itch [14]. 
However, scratching after AEW treatment develops with a latency of 3 days, suggesting that the 
sprouting fibers observed after a single treatment may be insufficient to induce itch [3, 4, 15]. The 
identity of the expanded peripheral fibers is not known, nor is it understood whether fiber 
hyperinnervation directly contributes to pruritus.  
In addition to possible changes in epidermal innervation, enhancement of pruritic receptor 
function and phenotypic switching of sensory neurons into pruriceptors may contribute to the 
increased itch generated by dry skin. Like many intractable pruritic conditions, AEW-induced itch 
is thought to be histamine-independent [3]. Novel non-histaminergic neural pathways and pruritic 
receptors have recently been identified [16]. Importantly, members of the Mas-related gene 
protein receptor family (Mrgprs) are activated by the non-histaminergic pruritogen chloroquine, 
and ablation of MrgprA3 resulted in decreased scratching after AEW treatment [17, 18]. MrgprA3 
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is functionally coupled to TRPA1, a channel that exhibits sensitivity to a wide range of irritants 
including mustard oil and formalin [19-22]. A significant reduction in scratching was observed in 
TRPA1 knock-out mice exposed to AEW treatment. Furthermore, AEW treatment induced 
upregulation of MrgprA3 mRNA, suggesting that these receptors may contribute to dry skin-
induced itch [7].  
The aim of this study was to determine the effects of dry skin pruritus on peripheral fiber 
anatomy and the physiological properties of sensory neurons innervating dry skin. Intraepidermal 
innervation was characterized and quantified with and without scratch-preventing Elizabethan 
collars to determine whether scratching itself contributes to changes in nerve fiber density in dry 
skin. We tested the hypothesis that dry skin produces peripheral sensitization by enhancing the 
excitability of trigeminal neurons. Finally, we monitored calcium responses evoked by chloroquine 
and mustard oil from AEW-treated and control animals to test for altered expression or function 
of itch-related receptors.   
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Materials and Methods 
Animals and Acetone-Ether-Water (AEW) treatment 
All experiments were conducted in accordance with the National Institutes of Health 
guidelines and received the approval of the Animal Care and Use Committee of Washington 
University, School of Medicine. 8-12 week old littermate mice (C57BL/6 (Jackson lab) or Ret-
EGFP [23, 24]) were housed on a 12 hour light-dark cycle and allowed ad libitum access to food 
and water. Ret-EGFP reporter mice (129/SvJ:C57BL/6) were obtained from Dr. Jain [23]. Cheek 
skin was shaved with electric clippers one day prior to the start of acetone-ether-water treatments. 
The acetone-ether group was treated with a 1:1 mixture of acetone and diethyl ether (Sigma, St. 
Louis, MO) for 30 seconds by soaking and then applying a gauze-wrapped cotton tip to the cheek, 
followed by similarly applied water for 30 seconds. Control animals were treated with water only. 
After 6 days of twice per day treatments (morning and evening), scratching behavior was 
quantified 6-8 hours after the final AEW treatment. Mice were placed in individual observation 
chambers and allowed to acclimate for 1 hour prior to observation. Bouts of scratching were then 
counted for 1 hour with experimenters blinded to treatment. A bout of scratching was defined as 
any number of individual scratch events separated by a pause. During the pause, behaviors such 
as licking or biting of the hind-limb, holding the limb motionless, or putting the limb down on the 
surface, could occur. Wiping behavior was taken to indicate pain and was defined as a rostrally-
directed movement of the ipsilateral forelimb across the cheek starting from the ear [5, 6]. 
Scratching behavior with continued AEW treatment has been reported to persist for at least 2 
weeks [4, 15]. 
  
Immunohistochemistry 
After six days of AEW treatment, mice were deeply anesthetized (ketamine-xylazine-
acepromazine: 38-1.92-0.38 mg/mL; 2.7 mL/kg). The treated skin was dissected and immersion-
fixed in Zamboni’s fixative for 4 hours, rinsed in PBS, and cryoprotected in 30% sucrose, then 
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sectioned at 30𝜇m and collected on slides. Wild type C57BL/6 mice were used to determine β-III 
tubulin, CGRP, and GFRα3 fiber innervation, while a separate strain of Ret-EGFP reporter 
mice[23, 24] were used to determine Ret-positive fiber density. Antibodies and dilutions: rabbit 
anti-βIII tubulin (1:1000, Covance), goat anti-CGRP (1:1000, Serotec), goat anti-GFRα3 (1:100, 
R&D Systems), rabbit anti-GFP (1:1000, Invitrogen), Alexa Fluor 488/555 donkey anti-rabbit 
(1:200-400, Invitrogen), Alexa Fluor 488 donkey anti-goat (1:200-350, Invitrogen). These 
concentrations are based on previous demonstrations of intraepidermal fiber staining [24-26]. 
Specificity of the GFRα3 antibody was previously shown using a GFRα3 knock-out mouse [27]. 
All slides were stained with bisbenzamide (1:40,000, Sigma, St. Louis, MO.) and MetaMorph 
Software (Molecular Devices, Sunnyvale, CA.) was used to measure the length of the dermal-
epidermal border. In each examined section labeled fibers crossing the dermal-epidermal border 
were counted on an upright epifluorescent microscope (Nikon 80i; CoolSnapES camera). Six 
examined sections separated by >60µm were analyzed for each animal and the mean fiber 
density was calculated. To determine whether changes in fiber innervation were dependent on 
scratching, modified Elizabethan collars (Harvard Apparatus, Holliston, MA.) were secured at the 
start of treatment in both AEW and water-only groups. For hematoxylin and eosin (H&E) staining, 
tissue was fixed in Zamboni’s fixative for 2-4 hours, then embedded in paraffin. Sections 10 µm 
thick were stained using standard H&E methods [28]. Representative images of fibers stained 
with the above-described methods were obtained using a Leica SPE Confocal microscope. 
Images were collected across the z-plane at 1µm width and maximum projection images were 
generated using ImageJ software.    
 
Culture of trigeminal ganglion neurons 
Wild type mice were sacrificed by decapitation after nine days of treatment and the 
ipsilateral trigeminal ganglia (TG) were removed and cut into several pieces. Ganglia were 
incubated in 45U papain (Worthington, Lakewood, NJ) in 3 mL Hank’s buffered saline solution 
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without Ca2+ or Mg2+ and with 10 mM HEPES at 37°C, 5% CO2 for 20 minutes. TG were washed 
and then incubated in collagenase (1.5 mg/ml) for 20 minutes. TG were triturated with a fire-
polished Pasteur pipette, then passed through a 40μm filter, and the dissociated cells were plated 
on poly-D-lysine and collagen coated glass coverslips. Cells were cultured overnight in 
Neurobasal A media supplemented with B27, 100U/mL penicillin/streptomycin, 2 mM Glutamax, 
and 5% fetal bovine serum (Gibco). No additional growth factors were added to the media. All 
experiments were performed within 24 hours of plating.  
 
Whole-cell patch clamp electrophysiology 
For electrophysiology experiments, FastDiI (Sigma, St. Louis, MO.) was injected 
intradermally into the cheek of wild type mice on day 2 of AEW or water treatment to label 
trigeminal neurons innervating the skin at the treatment site. After seven additional days of AEW 
or water treatment to allow maximum retrograde labeling of trigeminal neurons, including 
sprouting terminals, trigeminal ganglia were cultured as described above. Retrogradely labeled 
trigeminal neurons from AEW- or water-treated mice were then identified using an Olympus BX-
50 epifluorescence microscope and subsequently examined for differences in membrane 
excitability. Cells were tested in an external recording solution consisting of (in mM): 145 NaCl, 3 
KCl, 2.5 CaCl2, 1.2 MgCl2, 7 Glucose, and 10 HEPES, adjusted to pH 7.4 with NaOH and 305 
mOsm with sucrose. Borosilicate, filamented glass electrodes with 2-5 MΩ resistance (Warner 
Instruments, Hamden, CT) contained internal solution (in mM): 130 K-gluconate, 5 KCl, 5 NaCl, 
3 Mg-ATP, 0.3 EGTA, 10 HEPES, adjusted to pH 7.3 with KOH and 294 mOsm with sucrose. 
After acquiring gigaseal and break-in, neurons were given 2 minutes to stabilize and then a series 
of protocols to determine membrane excitability were performed. Action potentials were evoked 
in current clamp mode using a series of increasing 1 second ramp current injections. The first 
action potential of a train was used to determine threshold, defined as the voltage at which the 
first derivative of the membrane potential increased by 10 V/s. Rheobase was established from 
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the step current pulse at which the first action potential was triggered. Data were collected with a 
HEKA EPC 10 amplifier, digitized at 20 kHz, and recorded on a PC running Patchmaster software 
(v2x-71). Series resistance was kept below 10 MΩ in all recordings and only DiI labeled cells with 
a diameter less than 30 µm were studied.  
 
Calcium imaging 
The protocol for calcium imaging was adapted from our previous studies [29-32]. Cells 
from wild type mice were incubated for 45 minutes in 3 μg/mL of the cell-permeant ratiometric 
calcium indicator Fura-2 AM (Molecular Probes) and then incubated in external solution (in mM): 
130 NaCl, 5 K, 2 CaCl2, 1 MgCl2, 30 Glucose, 10 HEPES for a 30 minute de-esterification prior to 
recording. Coverslips were positioned in a recording chamber and perfused with external solution 
at room temperature. Cells were viewed under an inverted microscope (Olympus Optical, Tokyo, 
Japan) and images were captured with a Hamamatsu Orca camera. Regions of interest 
encompassing all Fura-loaded cells were identified a priori and the ratio of fluorescence emission 
at an alternating excitation wavelength of 357 and 380 nm was recorded with SimplePCI Software. 
The experimental protocol consisted of a 2 minute baseline followed by 30 second bath 
application of 100 μM mustard oil (MO, Sigma, St. Louis), 8 minutes of external solution, 30 
seconds of 1mM chloroquine (CQ, Sigma, St. Louis), 8 minutes of external solution, and 10 
seconds of high KCl (50mM). Peak responses were determined by calculating the absolute 
increase in Fura-2 signal above baseline immediately prior to each stimulus. A change from 
resting level of ≥20% was set as the threshold for a response to a bath applied chemical. Cells 
unresponsive to high K+ were excluded from physiological analysis.  
 
Statistical analyses 
All statistical analyses were performed using GraphPad Prism 6.04 (2014). For 
comparisons between AEW-treated and water-treated scratching behavior, unpaired t-test was 
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used to compare the total scratch bouts or wipes per 60-minute interval. Electrophysiological data 
comparisons were performed using unpaired t-test. Differences between the proportion of 
responders in AEW and water groups were determined using a χ2 test. Peak calcium increase in 
response to stimuli was analyzed with unpaired t-test. For all statistical analyses, significance was 
defined as p<0.05. Data are presented as mean ± S.E.M.  
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Results 
AEW-induced dry skin elicits scratching but not wiping behavior 
AEW treatment induced grossly visible, dry and scaly skin on the treated cheek of mice, 
whereas skin from water treated mice appeared unchanged (Figure 1A, B). AEW treatment also 
induced a hyperproliferation of keratinocytes resulting in thickening of the epidermis that was not 
observed in the water-only controls. The dry skin group was marked by spongiosis and large 
pieces of dissociating stratum corneum which still contained nucleated keratinocytes (Figure 1C, 
D). AEW treatment induced a significant increase in the number of site-directed bouts of 
scratching (H2O = 4.0 ± 2.3 scratch bouts, AEW = 60.7 ± 17.0 scratch bouts, unpaired t-test, 
p≤0.01; Figure 1E). In contrast, very little wiping behavior was observed in general and no 
difference in the number of wipes was observed between water-only and AEW treatment groups 
(H2O = 1.0 ± 0.8 wipes, AEW = 4.4 ± 1.7 wipes; unpaired t-test, Figure 1F). These results indicate 
that AEW-induced dry skin elicits ongoing itch without pain.  
 
Figure 1. Dry skin treatment induces itch without pain. A, B) Photographs of shaved mouse 
cheeks after treatment with water or acetone/ether and water. AEW treatment induced scaly, dry 
skin. C, D) H&E staining shows epidermal hyperplasia and hyperkeratosis in the AEW treated 
group but not in the water treated group. Stratum corneum still containing nucleated keratinocytes 
can be seen in the process of dissociating from the epidermis. Scale bar = 50µm. E, F) 
Quantification of the mean number of scratch bouts and wipes during 1 hour of observation after 
6 days of AEW treatment. AEW treatment greatly enhanced scratching (p< 0.01, unpaired t-test, 
water-treated n=9; AEW-treated n=11) but little wiping occurred and was not significantly different 
between water and AEW groups (n=5 each group, unpaired t-test). 
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Dry skin induces intraepidermal hyperinnervation independent of scratching 
To determine whether dry skin alters intraepidermal nerve fiber density (IENFD), we 
quantified fiber innervation in the cheek epidermis from AEW- and water-treated mice. IENFD 
was measured using an antibody against β-III tubulin, which is specific for neurons and labels 
axons and their terminals (Figure 2).[33] IENFD was significantly increased in the AEW-treated 
group compared to water-only controls (H2O = 26.8 ± 4.2 fibers/mm, AEW=44.1 ± 5.4 fibers/mm, 
n=5 animals per group, unpaired t-test, p<0.05) (Figure 2A - C).  
 
Figure 2. Dry skin induces intraepidermal hyperinnervation independent of scratching. A, 
B) Mice treated with acetone/ether and then water showed increased fiber innervation and 
epidermal hyperplasia compared to the water treated animals. Scale bar = 20µm. C) 
Intraepidermal fiber innervation was significantly increased by AEW treatment. D, E) Mice with 
Elizabethan collars placed at the start of treatment also showed increased fiber density and 
thickening of the epidermis. Scale bar = 20µm. F) No change in the magnitude of AEW-induced 
hyperinnervation relative to water-only controls was observed between collared and non-collared 
mice after AEW treatment.  
 
  Scratching itself is thought to promote itch via a positive-feedback loop known as the “itch-
scratch cycle”, and could alter fiber innervation. We sought to determine whether AEW-induced 
dry skin is itself capable of generating epidermal hyperinnervation, or whether scratching behavior 
was necessary to observe the increased IENFD. To this end, mice were fitted with Elizabethan 
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collars to prevent scratching of the cheek for the duration of the AEW and water treatments. AEW-
treated mice that wore collars also showed an increase in IENFD (H2O = 45.5 ± 1.8 fibers/mm, 
AEW = 70.2 ± 1.7 fibers/mm, n=3 animals per group, unpaired t-test, p<0.001) (Figure 2D, E). 
The magnitude of hyperinnervation relative to water controls (Fold Change) was not different 
between the no collar and collar groups (no collar = 1.5 ± 0.2 fold increase relative to water, n=5 
animals; collar = 1.5 ± 0.04 fold increase relative to water, n=3 animals, unpaired t-test, p=0.89) 
(Figure 2F), indicating that AEW treatment induced epidermal hyperinnervation independent of 
scratching.  
 
Dry skin selectively induces hyperinnervation by Ret-positive, non-peptidergic fibers 
Both peptidergic and non-peptidergic fibers are present in the epidermis and may 
contribute to pruritus. However, βIII-tubulin is an indiscriminant marker of nerve fibers. Therefore, 
to determine the subsets of sensory fibers that are increased in AEW-induced dry skin, peptidergic 
fiber density was assessed with an anti-CGRP antibody. There were no significant changes in 
CGRP-positive IENFD in the dry skin group when compared to water controls (H2O = 10.2 ± 1.4 
fibers/mm, AEW = 8.9 ± 2.1 fibers/mm, n = 5 animals per group, unpaired t-test, p=0.62) (Figure 
3A - C). Ret-EGFP reporter mice were used to identify Ret-positive (non-peptidergic) fibers, which 
were visualized using an anti-GFP antibody.[24] The density of Ret-positive epidermal fibers was 
significantly increased in the dry skin group (H2O = 40.2 ± 1.1 fibers/mm, AEW = 70.1 ± 7.6 
fibers/mm, n = 4 animals per group, unpaired t-test, p<0.01) (Figure 3D – F). A small subset of 
fibers that express both peptidergic and non-peptidergic markers can be identified by their 
expression of the artemin co-receptor GFRα3.[34] Intraepidermal fiber density of these fibers was 
quantified using an antibody directed against the GFRα3 receptor and no change in innervation 
after AEW treatment was observed (H2O = 16.0 ± 1.2 fibers/mm, AEW = 14.9 ± 2.0 fibers/mm, n 
= 4-5 animals per group, unpaired t-test, p=0.68) (Figure 3G-I). These data suggest that dry skin 
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induces branching and extension of non-peptidergic, Ret-positive epidermal fibers, which may be 
important for the development or maintenance of dry skin-induced itch. 
 
Figure 3. Hyperinnervation of Ret+, but not CGRP+ or GFRα3+ fibers after AEW treatment. 
A, B) Intraepidermal CGRP+ fibers appeared no different in the AEW and water groups. Scale 
bar = 20µm. Arrowheads indicate large pieces of dissociating stratum corneum which still 
contained nucleated keratinocytes. C) Quantification of CGRP+ density. D, E) Photomicrographs 
from a strain of mice in which eGFP is expressed from the Ret locus. eGFP immunostained fibers 
in the cheek epidermis show increased fiber density after AEW-treatment. Scale bar = 20µm. F) 
Quantification of Ret+ fiber density. G, H) IENFD of GFRα3+ fibers was not different between 
AEW and water groups. I) Quantification of GFRα3+ density.  
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We determined the proportion of trigeminal 
neurons projecting to the skin that were also Ret-
positive by intradermal cheek injection of the 
retrograde tracer DiI into untreated Ret-EGFP 
mice. Trigeminal ganglia were harvested and 
cultured and we found that the majority of 
retrogradely labeled neurons were also Ret-
positive (Figure 4A, B). Of all retrogradely labeled 
neurons, we found that 70.4 ± 4.1% were Ret-
positive (Figure 4C). Additionally, when tested for 
physiological responses to KCl, we found that 92.4 
± 2.7% of the KCl-responsive, DiI-positive cells 
were also Ret-positive (Figure 4C). This increased 
proportion of viable Ret-positive skin-projecting 
neurons suggests a small loss of Ret-negative 
neurons in culture.  
 
Effects of dry skin on trigeminal neuron 
physiology 
We hypothesized that AEW treatment could alter the membrane excitability of trigeminal 
neurons innervating the dry skin. We specifically targeted neurons with known peripheral 
projections by retrogradely labeling trigeminal neurons with DiI injected into the cheek skin of 
C57BL/6 AEW- and water-treated mice (Figure 5A). Whole-cell patch clamp electrophysiology 
was then used to assess changes in membrane excitability. Rheobase was assessed using a 
short step and action potential threshold was determined with the first spike evoked from a ramp 
current (Figure 5B, C). Resting membrane potential of trigeminal neurons was not significantly 
 
Figure 4. Retrograde labeling of 
trigeminal afferent fibers innervating 
the cheek. A, B) Two injections of DiI 
(10 uL each) into the cheek of an 
untreated Ret-EGFP mouse 
retrogradely labeled trigeminal ganglion 
neurons that were later cultured. Arrows 
show double-labeled neurons. C) 70.4 ± 
4.1% of all DiI+ neurons were also Ret + 
(n=10 coverslips, each circle represents 
% per coverslip); 92.4 ± 2.7% KCl-
responsive, DiI+ neurons were also 
Ret+ (n=5 coverslips). Total of 3 Ret-
eGFP mice used.  
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different between AEW- and water-treated mice (H2O = -60.8 ± 2.7 mV, n=14 neurons, AEW = -
57.2 ± 2.5 mV, n=15 neurons, unpaired t-test) (Figure 5D), and neither group showed 
spontaneous activity. There was also no significant difference in the current amplitude required 
to elicit an action potential between AEW- and water-treated animals (H2O = 614.3 ± 70.4 pA, 
n=15; AEW = 453.3 ± 50.0 pA, n=15, unpaired t-test) (Figure 5E). Action potentials evoked by a 
ramp current injection showed no difference between AEW and water treatment groups in the 
threshold for activation (H2O = -8.7 ± 3.7 mV, n=10; AEW = -3.8 ± 1.9 mV, n=12, unpaired t-test) 
(Figure 5F). Together, these data show that dry skin treatment did not produce ongoing activity 
or changes in membrane excitability that could be determined in vitro.  
 
Figure 5. Electrophysiology of AEW- and water-treated trigeminal neurons. A) 
Photomicrograph of a patched wild type trigeminal neuron retrogradely labeled from the cheek 
with DiI. (Scale bar = 30μm) B) Example trace of a short step protocol and evoked action potential 
to determine rheobase. C) Example traces of the ramp current and evoked action potentials from 
AEW- and water-treated trigeminal neurons. D) Resting membrane potential, E) Rheobase, and 
F) Action potential threshold were not different between AEW- and water-treated groups.   
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We next determined whether AEW-induced dry skin altered the responses of pruritic 
receptors and pruriceptive neurons. Trigeminal ganglion neurons from AEW- and water-treated 
wild type C57BL/6 mice were harvested, cultured, and loaded with Fura2-AM (Figure 6A). Wilson 
et al., (2013) showed that TRPA1 is crucial for dry skin-induced itch and that MrgprA3 mRNA is 
upregulated in sensory neurons after AEW treatment. To determine whether corresponding 
functional changes occur in trigeminal neurons, intracellular calcium was monitored to test the 
responses to the TRPA1 agonist mustard oil (MO) and non-histaminergic pruritogen chloroquine 
(Figure 6B). We observed no significant difference between AEW- and water-treated groups in 
the proportion of MO-responsive neurons (H2O = 89/1042 cells (8.54%), AEW = 107/1199 cells 
 
Figure 6. Increased calcium responses to chloroquine in AEW-treated trigeminal 
neurons in vitro. A) Image of Fura-2AM loaded trigeminal neurons with responses shown in 
B. (Scale bar = 50μm) B) Example traces of mustard oil (MO, 100 μM) and chloroquine (CQ, 
1 mM) responders, and a chloroquine responder without mustard oil sensitivity. C) 
Quantification of the proportion of neurons responsive and magnitude of the response to 
mustard oil from AEW- and water-treated animals. D) AEW increased the proportion of neurons 
responsive to chloroquine but did not alter the magnitude of the response.  
66 
 
(8.92%), χ2 test, p=0.81), or in the peak amplitude of the MO response (H2O = 101.4 ± 7% above 
baseline, AEW = 112.7 ± 6% above baseline, unpaired t-test, p=0.24) (Figure 6C). On the other 
hand, the proportion of CQ-responsive neurons in AEW-treated animals was significantly 
increased by 27.2% (H2O = 127/1042 cells (12.19%), AEW = 186/1199 cells (15.51%), χ2 test, 
p<0.05) (Figure 6D). Peak calcium responses to CQ were not different between the two groups 
(H2O = 73.4±4% above baseline, AEW = 68.7±3% above baseline, unpaired t-test, p=0.34).  
Most MO-responsive neurons also responded to CQ regardless of treatment (H2O = 77/89 
(86.5%), AEW = 93/107 (86.9%), χ2 test, p=1). Of the CQ-responsive neurons, most responded 
to MO in the water-treated group (77/127, 60.6%), while in the AEW group, half of CQ-responsive 
neurons responded to MO (93/186, 50.0%). Therefore, a large proportion of CQ-responsive 
neurons did not respond to MO. We tested whether the proportion of CQ-responsive neurons that 
did not respond to MO was increased in the AEW group, but this did not reach significance (χ2 
test, p=0.066). 
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Discussion 
Dry skin pruritus is a common problem and is often associated with other dermatoses. 
Here we show that persistent dry skin induced both pruritus and epidermal hyperinnervation in 
mice. We found that Ret-positive fibers contributed to the increased fiber density, but peptidergic, 
CGRP-positive and GFRα3-positive fibers did not. Moreover, preventing scratching of the affected 
area did not prevent dry skin-induced hyperinnervation. To understand whether sensitization or 
ongoing activity of sensory neurons contributes to persistent dry skin pruritus, we performed in 
vitro recordings from trigeminal neurons that were determined to have innervated the treated skin. 
No evidence was found supporting the hypothesis that altered membrane excitability was 
responsible for persistent dry skin itch. On the other hand, AEW treatment produced an increase 
in the proportion of trigeminal neurons responsive to the histamine-independent pruritogen 
chloroquine, supporting the concept that the Mrgpr family of receptors is upregulated and 
functionally contributes to persistent dry skin itch.   
In this study, AEW treatment of the cheek skin evoked scratching, but not forelimb wiping, 
indicating the treatment produced ongoing itch without pain. A common feature in the affected 
skin of patients with pruritic disease is increased epidermal innervation [9-11, 35]. Likewise, 
increased fiber growth in the murine epidermis after AEW treatment has been noted [12, 13]. 
Here, persistent AEW treatment increased total epidermal fiber density by 65%, as indicated by 
the pan-neuronal marker βIII-tubulin. We tested the possibility that mechanical stimulation from 
scratching contributed to the fiber growth. When Elizabethan collars were fitted to prevent 
scratching, intraepidermal innervation was still greater than in water-treated skin. The relative 
increase did not differ from the hyperinnervation observed in the AEW-treated animals without 
collars. These results demonstrate that dry skin itself is sufficient to induce hyperinnervation 
without the presence of scratching.   
In addition to hyperinnervation, histological studies of patients with atopic dermatitis or 
psoriasis indicate that itch severity correlates positively with nerve growth factor (NGF) in the skin 
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and the NGF-receptor TrkA in nerve fibers [9, 35-38]. Increased epidermal fibers and expression 
of NGF have been observed in a mouse model of atopic dermatitis [39, 40], and in mice with acute 
acetone-induced skin barrier dysfunction [12, 13]. While the specific contribution of 
hyperinnervation to itch sensation is not clear, these observations suggest the idea that 
peptidergic, TrkA-positive fibers may be important regulators of atopic and dry skin pruritus. The 
present study shows that repeated AEW treatment resulted in persistent dry skin itch, but we 
observed no increase of the CGRP-positive or GFRα3-positive fibers which likely express TrkA 
[34]. This may be due to differences between the biology underlying human atopic dermatitis and 
mouse models of acute dry skin. Our data do not rule out the possibility of functional contributions 
to dry skin itch from the CGRP-positive or GFRα3-positive subset of fibers or other peptidergic 
fibers, and it should be noted that fiber sprouting is not a prerequisite for sensory neurons to signal 
itch.  
A majority of the fibers innervating the epidermis are non-peptidergic and express the 
receptor tyrosine kinase for the GDNF family of neurotrophic factor ligands, Ret, rather than TrkA 
[24, 41]. GDNF release from skin keratinocytes and fibroblasts was recently acknowledged to 
play an important role in sensory neurite outgrowth in vitro with implications for pruritus [42]. 
Artemin, which activates Ret and GFRα3, is increased in human atopic skin and artemin-treated 
mice displayed increased sprouting of peripheral nerve fibers and itch-like behaviors [43]. 
Likewise, an increase in GFRα3 immunostained fibers was found in artemin over-expressing mice 
[25, 26]. However, in the AEW model of dry skin no sprouting of GFRα3-positive fibers was 
observed. Neurturin is another potentially interesting GDNF family ligand but its role in pruritus is 
currently unknown. The Mrgpr family of histamine-independent receptors has been shown to be 
selectively localized to Ret-positive DRG neurons and is expressed in epidermal nerve terminals 
[17, 18, 41, 44, 45]. Our results show that AEW treated skin resulted in a significant increase in 
Ret-positive fibers penetrating into the epidermis. This suggests that Ret-positive, non-peptidergic 
fibers could play a role in itch induced by dry skin.  
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The functional mechanisms engaged by pruriceptive sensory neurons to produce itch in 
dry skin conditions remain unresolved, but are thought to be independent of histamine signaling. 
Anti-histamines are generally not effective for treating chronic itch, including itch from dry skin [2, 
46]. Furthermore, mast cell-deficient mice exhibit normal scratching after AEW treatment, 
indicating that factors released from mast cells are unlikely to generate the itch from dry skin [3]. 
Recent studies have pointed to the involvement of specific non-histaminergic mechanisms for dry 
skin itch. For example, ablation of the chloroquine-activated MrgprA3-expressing subset of 
sensory neurons drastically reduced AEW-induced scratching [17]. Also, in vivo recordings from 
spinal dorsal horn neurons showed enhanced responses to non-histaminergic pruritogens after 
AEW treatment, but not to histamine [47]. Taken together, these studies support the idea that dry 
skin pruritus signals through a non-histaminergic pathway. 
Several signaling pathways for histamine-independent itch have now been identified. 
Scratching in mice deficient for TRPA1 was greatly reduced after chloroquine or AEW treatment, 
suggesting an important role for TRPA1 in non-histaminergic itch [7, 19]. Moreover, AEW 
treatment increased the message for MrgprA3 in both skin and sensory neurons [7]. MrgprA3, 
which functionally couples to TRPA1, is present on Ret-positive neurons, suggesting that dry skin 
itch involves non-peptidergic fibers [17]. Although TRPA1 was initially shown to be expressed in 
peptidergic sensory neurons [48], recent data have demonstrated robust modulation of TRPA1 
function in Ret-positive neurons and TRPA1 expression in non-peptidergic IB4-positive fibers that 
innervate the epidermis [25, 26, 49-52]. While the hyperinnervation of Ret-positive neurons is 
consistent with a potential role in dry skin itch, functional studies are necessary to determine 
whether changes in neural sensitization or receptor expression occur after AEW treatment.  
To gain insight into the functional changes of potential pruriceptive neurons exposed to 
dry skin, we hypothesized that locally released inflammatory mediators or neurotrophic factors 
act directly on pruriceptive sensory neurons to induce sensitization. Peripheral sensitization could 
explain the hyperknesis (heightened itch) and alloknesis (itch produced by a non-itchy stimulus) 
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commonly associated with pruritic diseases. To target neurons that directly innervated the treated 
skin, we performed whole-cell recordings from trigeminal ganglion neurons retrogradely labeled 
from the cheek skin of animals exposed to AEW or water treatment. With this strategy, we found 
no evidence for sensitization of trigeminal neurons in the AEW versus water-treated groups. It is 
possible that culture conditions reset differences that may have existed in vivo and future studies 
to examine the excitability of sensory fibers may yield different results. It is also possible that dry 
skin is associated with changes in excitability that are more pronounced at the fiber terminals in 
the skin and these did not translate into our in vitro studies of sensory neuron cell bodies. On the 
other hand, previous studies have shown that manipulations in vivo have produced altered 
sensory neuron physiology in vitro [53-55]. 
To test whether changes occur in the expression of functional pruritic receptors, we 
examined receptor-mediated responses to mustard oil and chloroquine in cultured trigeminal 
neurons from AEW- and water-treated animals. Interestingly, we found that AEW treatment 
expanded the population of sensory neurons with functional responses to chloroquine. In contrast, 
we found that responses to mustard oil were no different between AEW- and water-treated 
animals. These results mirror data showing an increase in mRNA for MrgprA3, but not TRPA1, in 
AEW-treated animals [7]. Overall, we found that ~10 percent of trigeminal neurons responded to 
mustard oil, which is consistent with the expression of TRPA1 in sensory ganglion in several 
reports [56-58]. While other studies have shown as many as 25% of sensory neurons are TRPA1-
positive, TRPA1 expression can vary by innervation target, exposure to growth factors, and 
changes in other experimental methods [21, 48, 51]. Interestingly, many of the neurons that 
responded to chloroquine after AEW showed no mustard oil responses at all, suggesting that the 
MrgprA3 receptor may couple to other channels in addition to TRPA1. In favor of this idea, 
MrgprA3 was recently found to modulate TRPM8, TRPC, and TRPV1 [59]. Additionally, TRPV3-
deficient mice exhibited greatly reduced scratching after AEW treatment compared to water-
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treated controls, indicating that other mechanisms in addition to TRPA1 may account for AEW-
induced scratching [14].  
In summary, our results show that dry skin-induced pruritus is associated with non-
peptidergic fiber growth into the epidermis and an expanded population of sensory neurons 
responsive to the non-histaminergic pruritogen chloroquine. Although sprouting of peptidergic, 
TrkA-positive fibers is observed in the skin of patients with atopic dermatitis and other 
dermatoses, our results suggest that non-peptidergic fibers may also play a role in chronic itch 
related to xerosis and compromised barrier integrity. Dry skin-induced itch, which particularly 
affects the older population and often co-exists with other dermatoses, may be improved by 
topical treatment directed at prevention of Ret-positive neural sprouting in the epidermis.  
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Chapter 4 
Neurotrophic factors selectively modulate pruritogen-evoked itch  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter is adapted from the following manuscript: 
Valtcheva MV, Golden JP, Sheahan TD, Pullen MY, Vogt SK, Jain S, Davidson S, Gereau RW. 
Neurotrophic factors selectively modulate pruritogen responses in mouse but not human sensory 
neurons. 2016. In Preparation.   
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Abstract 
Neurotrophic factors such as nerve growth factor (NGF) and the glial cell line-derived 
neurotrophic factor (GDNF) family of ligands (GFLs) regulate innervation and directly sensitize 
nociceptors, but little is known about their role in itch. Studies of skin samples from patients with 
chronic itch conditions such as atopic dermatitis and psoriasis demonstrate increased 
intraepidermal nerve fiber density, increased artemin, and increased NGF and its receptor TrkA. 
We tested the hypothesis that neurotrophic factors (NTFs) can modulate pruritogen-induced itch. 
We investigated whether NGF and the GFLs GDNF, neurturin, and artemin can directly induce or 
modulate histaminergic and non-histaminergic itch. Intradermal injection of NTFs into the cheek 
skin of mice did not induce spontaneous scratching or wiping behavior, indicating that NTFs alone 
do not induce pain or itch. Acute pretreatment with NGF selectively potentiated histamine-induced 
scratching. On the other hand, artemin enhanced chloroquine-evoked itch, but reduced histamine-
induced scratching. We studied dissociated trigeminal ganglion neurons from Ret-eGFP reporter 
mice to examine the effects of NGF and artemin on calcium responses to pruritogens and 
transient receptor potential (TRP) channel agonists. The vast majority of histamine- and 
chloroquine-responsive neurons were Ret-positive. Overnight incubation with NGF significantly 
increased the number of histamine responders. Both acute and overnight treatment with artemin 
increased the proportion of chloroquine-responsive neurons. We also found that TrkAF592A 
mutation resulted in altered TrkA signaling that produced an analgesic phenotype, but had no 
effect on histamine- or chloroquine-induced itch. Our findings indicate that NGF and artemin have 
select roles in the regulation of pruritogen-evoked itch. Additionally, TrkA signaling may not play 
a prominent role in the maintenance of pruriceptors in adulthood. These findings support the role 
of NTFs as regulators of histaminergic and histamine-independent itch. 
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Introduction 
Itch, or pruritus, is mediated primarily by small diameter primary afferents that innervate 
the skin and mucosa [1]. Pruriceptive nerve endings exist in close proximity to keratinocytes, 
dermal fibroblasts, and immune cells in the skin, which can release pruritogens, pro-inflammatory 
mediators, and neurotrophic factors (NTFs) that directly modulate primary afferent responses and 
receptor expression [1-7]. NGF and the GDNF family ligands (GFLs) regulate the development, 
morphology, target innervation, and physiology of peptidergic and non-peptidergic sensory 
neurons [8-12]. Previous studies indicate that a large proportion of neurons expressing pruritogen 
receptors also express TrkA and Ret, the tyrosine kinase receptors activated by NGF and GFLs, 
respectively [13-16]. NGF and the GFLs directly sensitize the transient receptor potential (TRP) 
channels TRPV1 and TRPA1, and can increase their expression in primary afferents [17-21].  
Histamine-evoked itch and sensory neuron responses are dependent on TRPV1 [20, 22, 23]. On 
the other hand, itch evoked by chloroquine is functionally dependent on TRPA1 [19, 21, 22]. 
These findings suggest that neurotrophic growth factors may play an important role in regulating 
normal and pathological itch.  
Pruritic skin diseases are marked by epidermal hyperplasia and increased inflammatory 
cell infiltration, which contribute to increased local levels of inflammation and NTFs. Studies of 
patients with atopic dermatitis and psoriasis have demonstrated that the severity of itch correlates 
with increased levels of nerve growth factor (NGF) in the skin and its receptor TrkA in epidermal 
nerve fibers [24-27]. A recent study also found that artemin, a glial cell line-derived neurotrophic 
factor (GDNF) family ligand, is increased in the skin of patients with atopic dermatitis [28]. In 
addition, intradermal injection of NGF in human subjects enhanced itch produced by the non-
histaminergic pruritogen cowhage [29], while intravenous administration of artemin for the 
treatment of sciatica resulted in frequent reports of pruritus [30, 31], further supporting a role for 
NTFs in the modulation or generation of itch.  
Neurotrophic factors are critical in the control of epidermal innervation, and epidermal 
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hyperinnervation is another common feature of pruritic skin diseases [27, 32, 33]. Indeed, cultured 
keratinocytes from patients with atopic dermatitis increased local NGF levels relative to healthy 
keratinocytes and produced greater axon growth in co-cultures with porcine sensory neurons [34]. 
TrkA inhibition in a mouse model of atopic dermatitis reduced both dermatitis-associated 
hyperinnervation and scratching behavior [35]. In addition, we recently found that the acetone-
ether-water model of dry skin itch is associated with epidermal hyperinnervation by Ret-positive 
fibers [36], suggesting a role for both NGF and the GDNF family ligands (GFLs) in the regulation 
of epidermal innervation in the context of itch. 
In this study we investigated the roles of the major peripheral NTFs in regulating the 
responses of sensory neurons to histamine and the histamine-independent pruritogen 
chloroquine. Using a TrkA receptor mutant, we further investigated whether endogenous growth 
factor signaling contributes to normal itch sensation and functional pruritogen receptor expression 
in trigeminal ganglion neurons.  
 
Materials and Methods 
Animals 
All experiments were conducted in accordance with the National Institutes of Health guidelines 
and received the approval of the Animal Care and Use Committee of Washington University in 
St. Louis, School of Medicine. Adult (8-12 week old) male littermate mice were housed on a 12 
hour light-dark cycle and allowed ad libitum access to food and water. The effects of nerve growth 
factor (NGF) and the GDNF family ligands GDNF, neurturin, and artemin on spontaneous and 
pruritogen-induced scratching behavior were tested in C57BL/6 (Jackson lab) male littermates. 
Heterozygous Ret-EGFP reporter animals were used to test the effects of neurotrophic factors on 
pruritogen responses in vitro [10, 37]. Homozygous TrkAF592A mutants (a generous gift from Dr. 
Wenqin Luo) and wild type littermates were obtained from heterozygous breeding pairs [38]. 
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Males aged 8 to 12 weeks were used for all behavior experiments. Males and females were used 
for calcium imaging and immunohistochemistry experiments.  
 
Pruritogen-induced scratching behavior 
Because of the well-established role of NTFs in pain sensitization, the cheek assay was 
used to differentiate between itch- and pain-specific effects of NTFs on behavioral responses to 
pruritogens [39]. At least one day prior to the start of behavior experiments, the cheek skin was 
shaved with electric clippers. On the day of experiment, animals were placed in individual 
plexiglass observation chambers and allowed to acclimate in the presence of white noise for 2 
hours. Using gentle restraint, animals were treated with a growth factor (0.2μg/10µl 0.9% normal 
saline solution) or vehicle (0.9% normal saline solution) by direct intradermal injection into the 
cheek skin using a 29½ gauge needle and 3/10cc insulin syringe. Neurotrophic growth factors 
used were: Nerve Growth Factor (Harlan), and GDNF, neurturin, artemin (R&D Systems). 
Behavioral responses were recorded immediately following injection using a video camera, and 
scratching and wiping behavior was scored at a later time by observers blinded to treatment. A 
single bout of scratching was defined as any number of individual scratch events separated by 
licking or biting of the hind-limb, holding the limb motionless, or putting the limb down on the 
surface. Wiping behavior indicating pain was defined as a rostrally-directed movement of the 
ipsilateral forelimb across the cheek starting from the ear [39, 40]. One hour after pre-treatment, 
animals were injected into the cheek skin with a pruritogen (histamine (1mg/10μl, Sigma) or 
chloroquine (200µg/10µl, Sigma)). Pruritogen-induced scratching and wiping responses were 
video recorded for 30 minutes immediately after injection and scored at a later time by observers 
blinded to pre-treatment. The number of scratch bouts from both treatment and vehicle groups 
were normalized to the vehicle mean for the day.  For TrkA mutant experiments, 8-12 week old 
TrkAF592A males and their wild type littermates were injected with histamine (500µg/10µl) or 
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chloroquine (200µg/10µl). Behavior was recorded and scored at a later time by experimenters 
that were blinded to mouse genotype.  
 
Primary trigeminal ganglion cultures and calcium imaging 
Experiments were performed using 8-12 week old Ret-EGFP reporter mice (C57BL/6) 
obtained from Dr. Sanjay Jain [37]. For TrkA mutant experiments, 8-12 week old homozygous 
TrkAF592A mutants and their wild type littermates were used. Animals were sacrificed by 
decapitation and both trigeminal ganglia (TG) were carefully removed and cut into several pieces. 
TG were incubated in papain (15U/ml) (Worthington, Lakewood, NJ) in Hank’s buffered saline 
solution without Ca2+ or Mg2+ and with 10 mM HEPES at 37°C, 5% CO2 for 20 minutes. TG were 
washed and then incubated in collagenase (1.5 mg/ml) for 20 minutes. TG were triturated with a 
fire-polished Pasteur pipette, passed through a 40μm filter to separate large debris, and the 
dissociated cells were plated on poly-D-lysine and collagen-coated glass coverslips. Cells were 
cultured overnight in Neurobasal A medium supplemented with B27, 100U/mL 
penicillin/streptomycin, 2 mM Glutamax, and 5% heat-inactivated fetal bovine serum (Gibco). No 
additional growth factors were added to the media unless otherwise stated for specific 
experiments. All calcium imaging recordings were performed within 24 hours of plating. For 
experiments using Ret-EGFP animals, two animals were sacrificed per experiment and all four 
trigeminal ganglia were pooled prior to plating the cells. Alternating coverslips were treated with 
NTF (100ng/ml) or vehicle. At least two experiments (n=4 animals) were used per study. For TrkA 
mutant experiments, TG from one mutant and one age-matched wild type littermate were cultured 
simultaneously, but maintained separately. 
The protocol for calcium imaging was adapted from our previous studies [41-44]. TG 
neurons from Ret-EGFP mice were incubated for 45 minutes in 3 μg/mL (3µM) of the cell-
permeant ratiometric calcium indicator Fura-2 AM (Molecular Probes) and then incubated in 
external solution (in mM): 130 NaCl, 5 K, 2 CaCl2, 1 MgCl2, 30 Glucose, 10 HEPES for a 20-
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minute de-esterification prior to recording. Coverslips were positioned in a recording chamber and 
continuously perfused with external solution at room temperature. Cells were viewed using an 
inverted microscope (Olympus Optical, Tokyo, Japan) and images were captured with a 
Hamamatsu Orca camera. Regions of interest encompassing all Fura-2-loaded cells were 
identified a priori and the ratio of fluorescence emission at an alternating excitation wavelength of 
357 and 380 nm was recorded with SimplePCI Software. The experimental protocol consisted of 
a 2-minute baseline measurement followed by bath application of the following stimuli 
(concentration, application duration, source): histamine (100 μM, 30 seconds, Sigma, St. Louis), 
chloroquine (1mM, 30 seconds, Sigma, St. Louis), capsaicin (200nM, 20 seconds, Sigma, St. 
Louis), mustard oil (100µM, 30 seconds, Sigma, St. Louis). Each stimulus application was 
followed by a wash with external solution for at least 8 minutes prior to subsequent stimulus 
applications. All experiments were concluded with a 10 second application of 50mM KCl to identify 
live neurons. Peak responses were determined by calculating the absolute increase in 357/380nm 
emission ratio above baseline (the average fluorescence measured in the 30 seconds 
immediately prior to stimulus application). A change from baseline ≥10% was set as the threshold 
for a response. Cells that did not respond to KCl were excluded from physiological analysis. Prior 
to recording, an image of EGFP-expressing neurons was captured. During data analysis, the 
EGFP image was overlayed with the regions of interest from the recording to identify which 
histamine- and chloroquine-responsive neurons were Ret-positive.  
 
Heat, Mechanical, and Cold Thresholds 
All behavioral experiments were completed between 8 AM and 6 PM. All animals were 
individually tested in clear plexigalss observation boxes after a 2-hour acclimation period in the 
presence of white noise. Experimenter was blinded to mouse genotype. Heat withdrawal latency 
was determined using the Hargreaves assay (Model 390 Series 8, IITC Life Science Inc.) 
performed on a glass plate maintained at 30°C [45]. Paw withdrawal latencies were determined 
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using a radiant heat stimulus set at 15% active intensity and 3% inactive intensity. Stimulus cut-
off was set to 20 seconds to avoid tissue injury. Five independent measurements were obtained 
for each paw, and consecutive trials on the same paw were separated by at least 15 minutes.  
To determine the 50% withdrawal threshold to mechanical stimuli, von Frey filaments were 
applied using the up-down method [46]. Calibrated von Frey filaments (North Coast Medical) were 
pressed against the hind paw skin between the anterior and posterior footpads until the filament 
just bent. A response was counted when a mouse lifted its hind paw away from the applied 
filament. Three trials were performed to determine the average withdrawal threshold (g) for each 
animal.  
Cold sensitivity was determined using the cold plantar assay [47]. Animals were 
acclimated on top of a ¼ inch glass plate. Finely crushed dry ice was tightly packed into a modified 
10 ml syringe to make a cold probe 1 cm in diameter. The cold probe was then applied to the 
glass beneath the hind paw and withdrawal latency was measured with a stopwatch. Three trials 
were conducted on each paw and consecutive trials to the same paw were separated by at least 
15 minutes. Stimulus cut-off of 20 seconds was used to prevent tissue damage.  
 
Immunohistochemistry 
TrkAF592A homozygous mice and wild type littermates were deeply anesthetized (ketamine-
xylazine-acepromazine: 38-1.92-0.38 mg/mL; 2.7 mL/kg), footpad skin was removed, and animals 
were perfused transcardially with phosphate-buffered saline followed by 4% paraformaldehyde 
solution. Footpads were immersion-fixed in Zamboni’s fixative overnight, rinsed in PBS, and 
cryoprotected in 30% sucrose. L4 DRG were dissected and cryoprotected in 30% sucrose. Tissue 
was embedded in optimal cutting temperature (OCT) compound and flash frozen on dry ice. 
Sections were cut on a cryostat at a width of 18µm (DRG) and 30 µm (footpad skin), and collected 
on glass slides. For immunostaining, tissue was post-fixed on the slide in 4% PFA for 5 minutes, 
washed with TBS, and blocked using 1% BSA and 0.05% TritonX-100. Sections were then 
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incubated in primary antibody diluted in Tyramide Signal Amplification (TSA) reagent overnight at 
4°C in a humidified chamber. Antibodies and dilutions used: rabbit anti-βIII tubulin (1:1000, 
Covance), goat anti-CGRP (1:350-1000, AbD Serotec), Alexa Fluor 488/555 donkey anti-rabbit 
(1:200-400, Invitrogen), Alexa Fluor 488 donkey anti-goat (1:200-350, Invitrogen). Slides were 
sealed with ProLong Gold with DAPI (Molecular Probes).  
Intraepidermal fiber density of the footpad skin was determined using previously described 
methods [10, 48]. MetaMorph Software (Molecular Devices, Sunnyvale, CA) was used to measure 
the length of the dermal-epidermal border. In each examined section, labeled fibers crossing the 
dermal-epidermal border were counted on an upright epifluorescent microscope (Nikon 80i; 
CoolSnapES camera). For each animal, six sections separated by >90µm were analyzed by a 
blinded experimenter and the mean fiber density per animal was calculated. Representative 
images of fibers stained with the above-described methods were obtained using a Leica SPE 
Confocal microscope. Images were collected across the z-plane at 1µm width and maximum 
projection images were generated using ImageJ software.   
 
Statistical analyses 
All statistical analyses were performed using GraphPad Prism 6.04 (2014). For 
comparisons of scratching behavior, unpaired t-test was used to compare the total scratch bouts, 
wipes, or normalized scratch bouts. For calcium imaging experiments, differences between the 
proportion of responders in each treated group were determined using a χ2 test, where each cell 
counted as an individual observation. Peak calcium increase in response to stimuli was analyzed 
using unpaired t-test. For all statistical analyses, significance was defined at p<0.05. Data are 
presented as mean ± S.E.M or overall proportion of responders (%).  
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Results 
Neurotrophic factors selectively modulate scratching responses to pruritogens 
Acute administration of neurotrophic factors can directly sensitize noxious responses to 
heat, cold, mechanical, and chemical stimuli [18, 49, 50]. To determine if neurotrophic factors can 
also acutely potentiate scratching responses to pruritogens, NGF, GDNF, neurturin (NRTN), or 
artemin (ARTN) were injected into the cheek skin of wild type mice. Scratching and wiping 
behavior was recorded immediately after growth factor injection to determine the direct effects of 
neurotrophic factors on spontaneous pain- and itch-specific behaviors. There were no significant 
differences in scratching or wiping behavior between the vehicle- and neurotrophic factor-treated 
groups, indicating that acutely administered NGF, GDNF, neurturin, or artemin alone do not 
directly induce pain or itch (Figure 1). To determine the effects of neurotrophic factors on 
histamine-dependent itch, one hour after NTF treatment all animals were injected with histamine 
 
Figure 1. Neurotrophic factors do not induce spontaneous itch or pain. A. Scratch bouts 
measured immediately after intradermal injection with neurotrophic factor (0.2µg/10µl) or 
vehicle (10µl 0.9% NaCl) (N=6-8 animals/group, t-test, p=NS). B. Wipes were measured 
immediately after NTF or vehicle injection.  
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into the cheek skin. NGF pre-treatment significantly potentiated histamine-induced scratching 
behavior (Figure 2A), but did not affect wiping. GDNF and neurturin administration did not affect 
histamine-induced scratching or wiping (Figure 2B, C). Pre-treatment with artemin significantly 
reduced histamine-induced scratching (Figure 2D), but did not affect wiping behavior. The effects 
of neurotrophic growth factors on histamine-independent itch were determined using the 
pruritogen chloroquine. One-hour pre-treatment with NGF, GDNF, and neurturin did not affect 
scratching or wiping behavior induced by chloroquine (Figure 2E-G). On the other hand, artemin 
 
Figure 2. Neurotrophic factors modulate scratching responses to pruritogens.  
A. Histamine-induced scratching was potentiated by NGF pre-treatment. B-C. GDNF and 
neurturin had no effect on histamine responses. D. Artemin pre-treatment reduced the total 
scratch bouts evoked by histamine. E-G. Chloroquine-induced scratching was not changed 
by NGF, GDNF, or neurturin. H. Artemin significantly potentiated chloroquine-evoked 
scratching responses. (N=7-10 per group, t test, *p<0.05, **p<0.01) 
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pre-treatment significantly potentiated chloroquine-induced scratching responses, with no effect 
on wiping behavior (Figure 2 H). These findings indicate that acutely applied NGF and artemin 
selectively modulate histaminergic and histamine-independent itch.  
 
NGF and artemin directly modulate sensory neuron responses to pruritogens 
To further investigate the mechanisms by which NGF and artemin potentiate itch, we used 
ratiometric calcium imaging to study trigeminal sensory neuron responses to pruritogens in the 
presence of these growth factors. A large proportion of chloroquine-responsive neurons express 
MrgprA3 and represent a specific subset of primary afferents that express both the peptidergic 
marker CGRP and the nonpeptidergic markers IB4 [13]. We utilized Ret-EGFP reporter mice to 
better characterize Ret expression in the subsets of functionally-identified histamine- and 
chloroquine-responsive neurons (Figure 3A-B). 
The effects of NGF on histamine responses were measured after acute 1-hour incubation 
or overnight incubation in NGF (100ng/ml) or vehicle. Because TRPV1 is activated downstream 
of histamine receptor activation and plays a key role in histaminergic itch, responses to capsaicin 
were also measured (Figure 3C). Of histamine-responsive neurons in the vehicle group, 80.3% 
were Ret-positive (n=71 cells, Figure 3D). Acute, 1-hour pretreatment with NGF did not change 
the total number of histamine-responsive neurons (N=78/482 vehicle cells (15.4%) vs. N=99/555 
NGF-treated cells (17.8%), χ2 test, not significant) or the peak calcium responses to histamine 
(Figure 3E). Similarly, 1-hour NGF did not change the proportion of capsaicin-responsive neurons 
(N=53/193 (27.5%) vehicle neurons vs N=68/226 (30.1%) NGF-treated neurons, χ2 test, not 
significant). Overnight incubation with NGF resulted in a significant increase in the proportion of 
histamine-responsive neurons (N=43/477 (9.1%) vehicle neurons vs. N=89/620 (14.4%) NGF-
treated neurons, χ2 test, p<0.01) (Figure 3F). There was no effect on peak calcium responses to 
histamine.  Overnight NGF treatment did not change the overall proportion of 
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Figure 3. NGF increases the proportion of histamine-responsive neurons. A, B. 
Representative images of Fura-2-labeled and Ret-EGFP-positive TG neurons. Arrows indicate 
cells labeled by both markers. C. Representative traces of neurons treated tested for histamine 
and capsaicin responses. D. Of histamine-responsive neurons (n=71), 80.3% were Ret+. E. 1-
hour pre-treatment with NGF did not affect the number or peak of histamine responses, or the 
proportion of capsaicin responsive neurons. F. Overnight pre-treatment with NGF increased 
the proportion of histamine-responsive neurons, but did not affect peak histamine responses 
or total capsaicin responsive neurons (χ2 test, **p<0.01). 
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capsaicin-responsive neurons. Neither treatment changed the proportion of histamine-responsive 
neurons that also responded to capsaicin (1-hour: 96.9% veh vs. 92.7% NGF; overnight: 90.1% 
veh vs. 87.6% NGF).  These results indicate that acutely applied NGF does not affect the number 
of histamine-responsive neurons in vitro. However, overnight exposure to NGF increased the 
proportion of histamine-sensitive neurons, suggesting an expansion of histamine receptor 
expression in previously histamine-unresponsive neurons.  
To determine whether artemin directly modulates sensory neuron responses to the non-
histaminergic pruritogen 
chloroquine, dissociated 
TG neurons from 
RetEGFP reporter 
animals were tested. 
Responses to mustard oil 
were also tested to 
determine if TRPA1 
modulation is another 
possible mechanism for 
the potentiation of 
chloroquine-induced itch 
(Figure 4A). In the 
vehicle-treated group, 
83.0% of the total 
chloroquine-responsive 
neurons were Ret-
positive (Figure 4B). 
Acute pre-treatment with 
 
Figure 4. Artemin increases the proportion of CQ-responsive 
neurons. A. Representative traces of neurons that were treated 
tested for chloroquine (CQ) and mustard oil (MO) responses. B. 
83% of chloroquine-responsive neurons were Ret-positive (n=93). 
C, D. Both 1 hour (C) and overnight (D) pretreatment with artemin 
(100ng/ml) significantly increased the proportion of chloroquine-
responsive neurons (χ2 test, *p<0.05, ***p<0.001). 
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artemin for 1 hour resulted in a significant increase in the proportion of chloroquine-responsive 
neurons from 10.9% in the vehicle group (N=104/956 cells) to 17.2% in the artemin-treated group 
(N=131/762 cells, χ2 test, p<0.001) (Figure 4C). Artemin pre-treatment did not affect peak calcium 
responses to chloroquine or the proportion of mustard oil-sensitive neurons (24.7% of vehicle- vs 
23.5% of artemin-treated neurons, χ2 test, not significant).  Overnight pre-treatment with artemin 
likewise increased the proportion of chloroquine-responsive neurons (N=51/429 vehicle neurons 
(11.9%) vs. N=84/508 artemin-treated neurons (16.5%), χ2 test, p<0.05), but did not change peak 
responses to chloroquine or the proportion of mustard oil-responsive neurons (Figure 4D). Neither 
treatment changed the proportion of chloroquine responders that also responded to mustard oil 
(1-hour: 72.1% vs. 71.8%; overnight: 66.7% vs. 63.1%). These findings indicate that acute and 
prolonged artemin pre-treatments significantly increase the proportion of chloroquine-responsive 
neurons in vitro, which may contribute to the potentiation of chloroquine-induced itch behavior.   
 
TrkAF592A mutation increases nociceptive detection thresholds but does not affect 
pruritogen-induced scratching 
To investigate whether endogenous NGF-TrkA signaling plays a role in regulating itch 
sensation and pruriceptor physiology, we obtained TrkAF592A mutant animals. These animals have 
a phenylalanine (F) to alanine (A) mutation in the ATP-binding pocket of TrkA that renders the 
receptor sensitive to pharmacological inhibition by the small molecule kinase inhibitor 1NMPP1 
[38]. We tested untreated homozygous mutants and their wild type littermates to confirm normal 
baseline pain and itch sensation. TrkAF592A mutants did not differ from their wild type littermates 
in body mass (n=4-5 per genotype, Figure 5A). However, homozygous TrkAF592A mutants with no 
pharmacological treatment had significantly increased baseline heat withdrawal latencies 
compared to their wild type littermates (N=7 per genotype, unpaired t test, *p<0.05) (Figure 5B). 
TrkAF592A mutants also demonstrated decreased sensitivity to mechanical and cold stimuli (Figure 
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5C-D). These results suggest that even without the use of pharmacological inhibitors, the 
TrkAF592A mutation has effects on endogenous TrkA function. Despite the observed effects on 
heat, mechanical, and cold detection 
thresholds, histamine- and chloroquine-induced 
scratching behavior was not different between 
TrkAF592A mutants and their wild type littermates 
(Figure 5E-F). These results indicate that the 
TrkAF592A mutation alters baseline nociceptive 
behaviors but does not affect pruritogen-evoked 
itch.  
NGF-TrkA signaling regulates sensory 
neuron survival during development and 
maintains target innervation and receptor 
expression in adulthood. The observed changes 
in pain detection thresholds may be due to loss 
of intraepidermal nerve fiber density or sensory 
neuron loss during development. To determine 
whether the TrkAF592A mutation results in a 
hypomorphic receptor, we used 
immunohistochemistry to quantify skin 
innervation. There was a significant decrease in 
βIII-tubulin immunoreactive epidermal nerve 
fibers in the footpad skin of TrkAF592A mutants 
when compared to wild type littermates, 
indicating a loss of total intraepidermal fiber 
density (Figure 6A-C). CGRP-positive fibers 
 
Figure 5. TrkAF592A mutation increased 
baseline heat, mechanical, and cold 
thresholds, but did not affect histamine- 
and CQ-evoked scratching responses. 
Mutants demonstrate normal body weight 
(A), but decreased nociceptive responses 
(B-D). Histamine- and chloroquine-induced 
itch was not different between genotypes (E-
F). (n=7 per genotype, unpaired t test, 
*p<0.05, **p<0.01).  
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were also significantly decreased in the mutant group, indicating a substantial loss of peptidergic 
innervation (Figure 6D-F).  
 
 
Figure 6. Altered TrkA signaling results in peptidergic intraepidermal fiber loss, but 
minor changes in sensory neuron responses to pruritoges and algogens. Representative 
images of βIII-tubulin-labeled intraepidermal fibers in wild type (A) and mutant (B) footpad skin. 
C. TrkAF592A mutants had a significant reduction on total intraepidermal fiber density (n=3-4 
animals per group, t test, **p<0.01). D-E. Representative images of CGRP+ fibers in wild type 
(D) and mutant (E), demonstrate the significant reduction in peptidergic fibers (F, n=3-4 
animals per group, t test, **p<0.01). Calcium imaging studies show a reduction in the 
proportion of histamine (G) and capsaicin (J) responders, but no effect on chloroquine- or 
mustard oil-responsive neurons (H-I) (χ2 test, *p<0.05, **p<0.01).  
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To determine whether altered NGF-TrkA signaling in the TrkAF592A mutant contributes to 
changes in pruriceptor and nociceptor subpopulations, we tested trigeminal neuron 
responses to the pruritogens histamine and chloroquine, and the algogens mustard oil 
and capsaicin. Despite the lack of behavioral effects on histamine-induced scratching, our 
data indicate a significant decrease in the overall proportion of histamine-responsive 
neurons from 13.3% to 9.1% in mutant animals (N=145/1089 +/+ neurons; N=78/853 
TrkAF592A neurons, χ2 test, p<0.01) (Figure 6G). There were no differences in the 
proportion of chloroquine- and mustard oil-responsive neurons (Figure 6H-I). TrkAF592A 
mutation resulted in a small but significant decrease in the proportion of capsaicin-
responsive neurons (N=270/819 (24.8%) wild type neurons versus N=172/681 (20.2%) 
TrkAF592A neurons, χ2 test, p<0.05) (Figure 6J). These findings indicate the TrkAF592A 
mutation likely alters endogenous TrkA signaling, resulting in a substantial loss of 
peripheral target innervation. Population studies using calcium imaging suggest that 
histamine- and capsaicin-responsive subpopulations depend on TrkA activity, while 
chloroquine- and mustard oil-responsive neurons may be maintained via TrkA-
independent mechanisms.  
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Discussion 
Chronic pruritus is a tremendous clinical problem associated with a number of 
dermatological diseases, including atopic dermatitis and psoriasis. Lesional skin in pruritic 
conditions exhibits increased levels of growth factors and epidermal innervation [24-27], 
suggesting that neurotrophic growth factors contribute to pruriceptor fiber growth and excitability. 
Here we investigated the direct effects of NGF and the GDNF family ligands on pruritogen-evoked 
itch behaviors and sensory neuron responses in vitro. Our data demonstrate distinct roles for NGF 
and artemin in the modulation of histamine- and chloroquine-evoked itch, respectively. Using 
TrkAF592A mutants, we tested the role of endogenous TrkA signaling in the maintenance of 
pruriceptors in adulthood, and determined that pruriceptive neurons are likely supported by TrkA-
independent mechanisms.  
The role of NGF in nociceptor plasticity has been extensively studied [51], yet little is 
known about the direct effects of NGF on pruriceptor physiology. Increased serum and skin levels 
of NGF in atopic dermatitis, prurigo nodularis, and psoriasis, suggest a role for NGF-TrkA 
signaling in the induction or maintenance of chronic pruritus [24-26, 52, 53]. Several studies have 
demonstrated acute application of NGF induces thermal and mechanical hyperalgesia in both 
rodents and humans [50, 51, 54-60]. One study tested the effects of a single intradermal injection 
of NGF on pruritogen-induced itch in healthy human volunteers, and determined that there was a 
potentiation of cowhage-induced itch, but not histamine-induced itch [29]. These results contrast 
with our finding that acutely applied NGF selectively potentiated histaminergic itch in mice. One 
factor that may contribute to this difference is the timeline of treatment. In the human study, 
investigators tested pruritogen responses at days 7 and 21 after NGF treatment, in order to 
coincide with previously identified peak of thermal and mechanical hyperalgesia, respectively. 
The 1-hour time point applied in our study likely restricts the effects of NGF to local receptor 
expression or sensitization at the fiber terminals, but it does not provide enough time for broad 
transcriptional or fiber growth changes to take place in trigeminal neurons [61]. The effects of 
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NGF treatment in humans one hour after intradermal injection remain unknown, but our findings 
suggest that acute sensitization of histamine-responsive fibers could occur.  
To investigate the direct effects of NGF on pruriceptive neurons and identify a potential 
mechanism for the sensitization observed in vivo, we measured dissociated trigeminal neuron 
calcium responses to histamine after treatment with NGF. Overnight incubation with NGF resulted 
in a significant increase in the number of histamine-responsive neurons, but acute 1-hour 
treatment had no effect. The lack of acute effect observed in culture suggests that NGF-induced 
sensitization of histamine-evoked itch may be dependent on NGF activation of local inflammatory 
cells such as mast cells to release mediators that can directly activate or sensitize afferent fibers 
innervating the skin [62, 63]. The expansion of the histamine-responsive proportion of neurons 
with prolonged overnight treatment suggests that NGF is a transcriptional regulator of histamine 
receptors in neurons and can induce expression in neurons that were previously histamine-
insensitive. Unexpectedly, NGF pre-treatment did not alter the proportion of capsaicin-responsive 
neurons, despite its well-known contribution to TRPV1 expression and sensitization. In summary, 
our data indicate that NGF increases histamine receptor expression in sensory neurons, 
suggesting that NGF may be a transcriptional regulator for receptors involved in itch, as well as 
pain.  
Studies have demonstrated that GFLs can also induce hyperalgesia by direct sensitization 
of nociceptors and modulation of nociceptor phenotypes. Acutely, all three GFLs sensitize TRPV1 
to produce thermal hyperalgesia. Inflammation and neuropathy models demonstrate that artemin 
and its co-receptor GFRα3 are upregulated and mediate cold hyperalgesia [49, 64] . On a more 
chronic scale, overexpression studies show that artemin increases both the expression of TRPV1 
and TRPA1 and intraepidermal fiber innervation, which contribute to increased sensitivity to heat, 
cold, and chemical stimuli [17, 65].  
We determined the effects of the GNDF family ligands (GFLs) GDNF, neurturin, and 
artemin on pruritogen-evoked itch. Our findings indicate that GNDF and neurturin do not affect 
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pruritogen-evoked itch, while artemin potentiates chloroquine-induced itch but suppresses 
histamine responses. To activate the receptor tyrosine kinase Ret, each GFL requires a specific 
co-receptor known as the GDNF receptor α (GFRα1-4), conferring GFL-cell type specificity [8]. 
MrgprA3-positive neurons represent a subset of the chloroquine-responsive population, and 
molecular studies using reporter mice demonstrate that this group of cells expresses both the 
peptidergic marker CGRP, and the non-peptidergic marker Ret [13, 66]. Our calcium imaging 
studies in Ret-EGFP reporter mice indicate the vast majority of functionally identified chloroquine-
sensitive neurons are indeed Ret-positive. The artemin co-receptor GFRα3 is also found in 
sensory neurons that express Ret, TrkA, and peptidergic markers such as TRPV1 and CGRP [49, 
65, 67], suggesting that MrgprA3 and GFRα3 may colocalize to the same population. 
Furthermore, artemin was previously demonstrated to enhance warmth-induced “itch-like” 
grooming responses in mice [28], and clinical trials testing artemin as a potential treatment for 
sciatica found the most commonly reported adverse effect (occurring in more than 40% of 
participants) was pruritus [30, 31]. These findings support the idea that artemin can acutely 
sensitize itch responses to non-histaminergic pruritogens. Furthermore, our calcium imaging 
studies demonstrate that artemin increased the proportion of chloroquine-responsive neurons in 
culture, indicating artemin may also be a transcriptional regulator of chloroquine receptor 
expression.  
To determine the role of endogenous TrkA signaling in the maintenance of pruriceptors in 
adulthood, we used the TrkAF592A mutant.  Despite no reports of a detrimental effect on neuronal 
survival in the early postnatal period [38], we found that the TrkAF592A mutation resulted in 
significant intraepidermal fiber loss and increased pain detection thresholds in adulthood. These 
findings are consistent with the analgesic phenotypes of NGF/TrkA knock-out animals [68, 69], 
suggesting that this mutation alters normal TrkA signaling and likely results in a hypomorphic 
receptor.  Interestingly, pruritogen-evoked itch and sensory neuron responses in these animals 
remained largely intact. In vitro studies of sensory neurons demonstrate a small but significant 
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reduction in the proportion of histamine- and capsaicin-responsive neurons. Prior studies have 
demonstrated the proportion of histamine-responsive neurons can range between approximately 
10-15%, which may explain why this reduction did not result in robust in vivo effects. These 
findings suggest that endogenous NGF-TrkA signaling may not be required for the maintenance 
of pruriceptive fiber innervation and functional pruritogen receptor expression in adult sensory 
neurons. However, further characterization of sensory neuron loss and receptor activation is need 
to clarify the extent functional loss in these mutants.  
 In summary, we tested the hypothesis that neurotrophic factors regulate pruritogen-
induced itch and sensory neuron responses. We found NGF and artemin have distinct roles in 
the sensitization of histaminergic and histamine-independent itch. In addition, NGF and artemin 
regulate pruritogen receptor expression in vitro, suggesting a potential mechanism for itch 
sensitization in pruritic skin diseases where high levels of growth factors can be found in the skin. 
Furthermore, a mutation in the high-affinity NGF receptor TrkA confirms its involvement in 
nociceptor maintenance, but indicates it may not be required for normal itch responses. 
Neurotrophic growth factors represent potential clinically relevant mediators of itch and further 
studies should explore their role in chronic and inflammatory itch mechanisms. 
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Chapter 5 
Functional studies of human sensory neuron responses to pruritogens 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter is adapted from the following manuscripts: 
 
Valtcheva MV*, Copits BA*, Davidson S, Sheahan TD, Pullen MY, McCall JG, Dikranian K, 
Gereau RW. Surgical extraction of dorsal root ganglia from organ donors and preparation of 
primary human sensory neuron cultures. Nature Protocols. 2016. In Press.  
 
Valtcheva MV, Golden JP, Sheahan TD, Pullen MY, Vogt SK, Jain S, Davidson S, Gereau RW.  
Neurotrophic factors selectively modulate pruritogen responses in mouse but not human sensory 
neurons. 2016. In Preparation.  
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Abstract 
Primary cultures of rodent sensory neurons are widely used to investigate the cellular and 
molecular mechanisms involved in pain and itch. The translation of preclinical findings into 
effective patient therapies may be greatly improved by direct validation in human tissues. We 
developed an approach to extract and culture human sensory neurons in collaboration with a local 
organ procurement organization. Here we describe the surgical procedure for extraction of human 
dorsal root ganglia (hDRG) and the culture techniques used to prepare viable adult human 
sensory neurons for functional studies. Dissociated sensory neurons can be maintained in culture 
for more than 10 days, and are amenable to electrophysiological recording and calcium imaging. 
We further applied this approach to determine the effects of growth factors on human pruriceptor 
populations. Our findings indicate that NGF and artemin did not change the proportion of 
pruriceptive neurons, suggesting different mechanisms may be involved in the sensitization of 
mouse versus human sensory neurons. The approach we have developed can be applied at any 
institution with access to organ donors that consent to tissue donation for research and provides 
an invaluable resource for improving translational research.  
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Introduction 
Preclinical studies of pain, itch, nerve injury, regeneration, and axonal transport rely 
heavily on the use of primary cultures of dissociated rodent sensory neurons. Many candidate 
molecular targets and genes have been identified using this approach, yet few of these findings 
have directly translated into effective and safe clinical treatments [1-5]. Several notable failures in 
translation have raised questions about possible differences in fundamental biological 
mechanisms between humans and rodents [6-12]. For example, NK1 receptor antagonists failed 
to provide significant analgesia in humans, despite strong preclinical effects in rodents [6]. In 
addition, GABAA receptor-mediated currents in cultured human sensory neurons were recently 
found to exhibit distinct biophysical features from those in rodents, demonstrating the importance 
of preclinical validation between species [13-16]. 
Recent advances in induced pluripotent stem cell (iPSC) methods have produced 
nociceptor-like cells derived from human fibroblasts that express TRP channels and can be 
sensitized by inflammatory mediators such as PGE2 [17, 18]. Unlike sensory neurons obtained 
from organ donors, such methods are not restricted by donor availability because they do not rely 
on post-mortem tissue collection and can be further strengthened by a living donor’s developing 
medical history. However, the iPSC approach is still significantly limited by low nociceptor 
conversion rates (<5%) and the use of varying transcription factor combinations to produce 
nociceptor-like populations. While both approaches can be informative, direct studies in human 
sensory neurons may more accurately recapitulate the complex overlapping sensory neuron 
subpopulations and downstream signaling cascades involved in sensory processing.   
Cultured human sensory neurons can serve as a valuable tool in functional and genetic 
studies to validate the numerous molecular targets identified in animal models. By using 
techniques such as patch-clamp electrophysiology, calcium imaging, immunohistochemistry, 
gene knock-down, and viral gene transfer, the fundamental physiological properties of human 
sensory neurons can be more accurately characterized. These approaches could lead to the 
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discovery of novel target receptors or channels and allow for in-depth characterization of 
pharmacological agents in native human cells. Furthermore, the potential of novel therapeutic 
interventions involving gene therapies, and optogenetic and chemogenetic manipulations of 
cellular activity can be verified directly in human sensory neurons.  The protocol we developed 
allows us to obtain DRG from multiple spinal levels, giving us the opportunity to culture from half 
of the ganglia, while preserving the remaining tissue for RNA sequencing and 
immunohistochemical analysis. This permits parallel functional and gene expression studies from 
the same donor with the ability to correlate observations with patient medical record information 
[14, 16, 19]. Future studies employing a combination of these approaches can help identify human 
biomarkers for chronic pain and itch. 
Recent studies in the field of itch have identified the Mas-related G protein-coupled 
receptor (Mrgpr) subtypes A3 and C11 as key mediators of acute and chronic itch in mice [20-
22]. However, these receptors are not evolutionarily conserved in humans, which instead have 
four MRGPRX receptors (MRGPRX1-4). Studies using heterologous systems have determined 
that the human MRGPRX1 receptor can be activated by both MrgprA3 and MrgprC11 agonists, 
although key differences in the pharmacological and signaling profiles of these receptors indicate 
distinct molecular mechanisms in mice versus humans [20-24]. In this study, we demonstrate the 
pruriceptive subpopulations of human sensory neurons that respond to histamine and 
chloroquine, and their functional overlap with TRP channels. In our prior studies we determined 
that NGF and artemin increased the proportion of histamine- and chlroquine-responsive neurons 
in mouse. We now test the effects of these growth factors in human sensory neurons and use 
RNA sequencing to determine the expression of pruritogen receptors, TRP channels, and 
neurotrophic growth factor receptors in whole human DRG.  
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Materials and Methods 
Access to human donor tissue 
We established a collaboration with Mid-America Transplant, a local organ procurement 
organization. Extraction procedures were approved by Mid-America Transplant and appropriate 
regulatory documentation and agreements were obtained, including IRB waiver from the Human 
Research Protection Office at Washington University in St. Louis and material transfer agreement. 
Mid-America Transplant obtained documentation of donor or family consent to tissue donation for 
research and provided access to all medical records available at procurement. Since establishing 
this approach at our institution, we have had access to donor tissue approximately 1-2 times per 
month. Once a donor becomes available and consent has been obtained for tissue donation to 
research, we are contacted by Mid-America Transplant staff, generally 3-8 hours prior to organ 
procurement.  
 
Surgical extraction of human dorsal root ganglia (hDRG) 
Sterile operating room procedures were followed throughout tissue extraction in order to 
not interfere with further tissue procurement after DRG have been removed. Once the transplant 
surgical team completed the extraction of all organs to be used for transplantation (e.g. liver, 
kidneys, heart), all remaining viscera were either retracted or removed.  The lumbar spinal column 
was exposed by removing the abdominal vasculature, including the abdominal aorta, inferior vena 
cava, and lymphatics, and remaining connective tissue located anterior to the spine in the 
retroperitoneal space. The psoas major and psoas minor muscles were cut and retracted or 
removed from their origin to expose the lateral aspects of the spinal column and the roots of the 
lumbar plexus. Using a mallet and straight osteotome, L1 and L5 vertebral bodies were 
transected, stopping at the spinal canal (Figure 1a). With the use of a mallet and curved 
osteotomes, the pedicles were transected bilaterally between L1 and L5, while staying close to 
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the posterior edge of the vertebral bodies, but anterior to the spinal canal (Figure 1b). The entire 
anterior portion of the vertebral column between L1 and L5 was manually removed by lifting 
carefully to minimize tearing of structures in the intervertebral foramina and simultaneously cutting 
any dural attachments to the posterior longitudinal ligament (Figure 1c). This approach ensured 
that the transverse processes, laminae, and spinous processes remain in place. It is essential to 
leave the dorsal portion of the vertebral column intact to maintain the integrity of the body for 
 
Figure 1. Surgical extraction of hDRG using ventral approach. (a-b) Illustration depicting 
the ventral (a) and lateral (b) views of the spinal column with lumbar vertebral bodies L1 and 
L5 indicated by arrows. Red dashed lines indicate the location of bone transection. After the 
spinal column is visualized, lumbar vertebrae can be correctly identified by counting up from 
L5, which is located directly above the sacrum (a,b). Using a straight osteotome and surgical 
mallet, the L1 and L5 vertebral bodies are transected, stopping at the spinal canal (red dashed 
lines in panel a, black lines indicate transected bone in panel b). Using a curved osteotome 
and mallet or autopsy saw, the pedicles of each vertebrae are transected bilaterally between 
L1 and L5 (red dashed lines in panel b). (c) Illustration showing the anterior portion of the 
vertebral column removed to expose the spinal canal where the cauda equina and DRG are 
located (TP: transverse process, CE: cauda equina, PLL: posterior longitudinal ligament, DM: 
dura mater, DRG: dorsal root ganglion). (d) Each DRG is dissected away from surrounding 
bone and connective tissue and the nerve roots and rami are cut to completely free each 
ganglion (red dashed lines).  
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further tissue procurement and funeral service purposes. When devising our approach, this was 
a major concern for Mid-America Transplant.  
DRG were visualized by a gentle tug on the dura mater and each ganglion was dissected 
away from surrounding connective tissue and bone using DeBakey pick-ups and dissecting 
scissors. The spinal roots and rami of peripheral nerves were then cut to completely free the DRG 
(Fig. 1d). Each DRG was fully submerged in ice-cold N-methyl-D-glucamine artificial 
cerebrospinal fluid solution (NMDG-aCSF) in air-tight 50 ml conical tubes and maintained on ice 
for transport. NMDG-based aCSF solutions reduce neuronal permeability to sodium and calcium, 
reduce oxidative stress, and are very beneficial for producing adult rodent brain and spinal cord 
slices for electrophysiological recordings [25-28].  DRG tissue from human organ donors was 
extracted as soon as possible to minimize post-mortem interval. We were generally able to extract 
DRG 1.5-3 hours post-mortem, immediately after the surgical resection of organs for 
transplantation. However, we have obtained viable neuron cultures from tissues extracted up to 
4 hours post-mortem.  
 
Cleaning and dissection of DRG 
Upon return to the laboratory, each individual DRG was placed in a 60 mm petri dish filled 
with ice cold NMDG-aCSF and maintained on ice for the duration of cleaning and dissection. 
Using large spring scissors and forceps, any remaining fat and connective tissue surrounding 
DRG were removed (Figure 2a).  With the aid of a dissection microscope, forceps and large spring 
scissors were used to identify the edge of the dura along the severed ends of the central and 
peripheral nerve processes. The dura was then cut longitudinally from the peripheral to the central 
endings. The dura was removed by continually pulling away from the ganglion and cutting along 
the edge where the dura meets the DRG and nerves (Figure 2b). The remaining central and 
peripheral nerve processes were trimmed with a scalpel, so that only the ganglion body remained 
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(Figure 2c). One ganglion from each spinal level was used for culture, while the corresponding 
contralateral DRG was saved for immunohistochemistry and RNA sequencing studies, to allow 
for direct functional comparisons. Once the contralateral ganglion was cleaned, it was cut into 
small pieces and part of the tissue was immediately frozen in RNAlater for RNA sequencing or 
RT-PCR, while the rest of the DRG was post-fixed in 4% paraformaldehyde solution for intact 
ganglion histology.  
 
Dissociation and culturing of DRG 
Each DRG to be used for culture was minced with a scalpel as finely as possible into 
pieces no larger than 3 mm in diameter. All tissue fragments were placed into a 14 ml snap-cap 
tube containing 3 ml of pre-warmed (37°C) papain/NMDG-aCSF solution (1.5U/ml) and incubated 
for 1 hour at 37°C and 5% CO2. The tube was gently agitated every 20 min to mix tissue with 
solution. The tissue was washed carefully 3 times with 3 ml of fresh NMDG-aCSF, warmed to 
37°C. The tissue was then incubated in 3 ml of NMDG-aCSF-collagenase (15mg/ml) solution for 
1 hour at 37°C and 5% CO2, while agitating gently every 20 min to mix the tissue with the solution. 
Tissue was carefully washed 3 times with 3 ml of fresh NMDG-aCSF warmed to 37°C. The 
remainder of NMDG-aCSF solution was then removed and 2 ml of pre-warmed DRG medium 
were added. DRG tissue was then triturated gently through the fire-polished tip of a sterile glass 
 
Figure 2. Cleaning of hDRG prior to dissociation. (a) Extracted ganglia are first cleaned of 
all visible fat and connective tissue. (b) Dura mater is then removed to expose underlying 
ganglion and nerve roots and rami. (c) Nerve roots are trimmed so that only the ganglion 
remains for dissociation. Scale bars represent 1 cm.  
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Pasteur pipette until the solution became cloudy and little resistance remained (approximately 10-
20 times). The solution of dissociated neurons was carefully passed through a 100 μm sterile filter 
into a 50 ml conical tube. The filtrate was centrifuged at room temperature for 4 min at 180g. The 
supernatant containing debris was carefully removed and the pellet was re-suspended in 1 ml 
warmed DRG medium by pipetting up and down several times. Cell suspension was centrifuged 
again for 3 min at 180g.  The supernatant was removed and the pellet was re-suspended in 1 ml 
warmed DRG medium by mixing gently. At this point, the cell suspension was counted using a 
hemocytometer and diluted to desired concentration. The cell suspension was plated onto poly-
D-lysine and collagen-coated glass coverslips for a final plating density of approximately 500 
cells/coverslip. The cell-plated coverslips were incubated at 37°C, 5% CO2 for 1-1.5 hours to allow 
neurons to adhere to the glass and then 900 μl warm DRG medium was added. Dissociated 
hDRG cultures were maintained at 37°C, 5% CO2 in a humidified chamber until use. Half of the 
culture medium was replaced with fresh warmed medium every 3-4 days. 
 
Reagents 
Poly-D-lysine (PDK) solution was made by dissolving 5 mg PDK in 50 ml sterile water, 
aliquoted into 1 ml (0.1 mg/ml) per tube, and stored at -20°C. Rat tail collagen (Sigma) was 
dissolved in sterile water for a final concentration of 1 mg/ml and stored at 4°C up to 2-3 months. 
PDK/collagen solution was made at a final concentration of 0.01 mg/ml PDK and 0.2 mg/ml 
collagen. Papain solution was made by adding 0.5 μl of 0.5 M NaOH to 1 mg/50μl L-cysteine and 
then combined with 45U papain in 3 ml of NMDG-aCSF. Solution was made fresh and warmed 
to 37°C immediately prior to use. DRG medium was Neurobasal A media supplemented with B27, 
100U/mL penicillin/streptomycin, 2 mM Glutamax, and 5% fetal bovine serum (Gibco). For 
electrophysiology experiments, neurotrophic factor (NTF)-treated neurons were plated in the 
presence of 25ng/ml human β-nerve growth factor (hNGF) (Cell Signaling Technology) and 
recombinant human glial cell line-derived neurotrophic factor (hGDNF) (Peprotech).  
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NMDG-artificial cerebrospinal fluid (aCSF) solution: The reagents listed in Table 1 were combined 
in 450 ml Milli-Q H2O in the order listed. pH was adjusted to 7.4 with NMDG/HCl and osmolarity 
was adjusted to 300-310 mOsm with H2O or sucrose [25, 26]. NMDG-aCSF solution was always 
made fresh and bubbled with carbogen gas (95% O2, 5% CO2) for at least 15 min prior to use to 
achieve stable pH and saturate with oxygen.  
Table 1. Reagents used to prepare NMDG-aCSF.  
Reagent 
Final 
Concentration 
(mM) 
MW or 
Concentration 
of stock 500 ml 
NMDG 93 195.2 9.08 g 
HCl  12.1 N 3.5 ml 
KCl  2.5 2.5 M 500 μl 
NaH2PO4  1.25 1.25 M 500 μl 
NaHCO3 30 84.0 1.26 g 
HEPES  20 2 M 5 ml 
Glucose  25 2.5 M 5 ml 
Ascorbic acid 5 176.1 0.44 g 
Thiourea 2 76.1 0.08 g 
Na+pyruvate 3 110.0 0.17 g 
MgSO4  10 2 M 2.5 ml 
CaCl2  0.5 1 M 250 μl 
N-acetylcysteine 12 163.2 0.98 g 
 
Immunocytochemistry 
Coverslips of dissociated neurons were fixed in 4% paraformaldehyde/ 4% sucrose. 
Antibodies used include: Rabbit anti-TRPV1 (1:800), custom-made serum directed against the 
TRPV1 C-terminus peptide CLKPEDAEVFKDSMVPGEK, specificity confirmed in TRPV1-/- mice 
[29, 30]; Mouse anti-βIII-tubulin (1:2000) – EMD Millipore (cat. no. 05-559), species reactivity 
(hm/bv/rat/ms), Antibody Registry ID: AB_309804; Guinea pig anti-GFAP (1:1000) – Synaptic 
Systems (cat. no. 173 004), species reactivity (hm/rat/ms/ck), Antibody Registry ID: 
AB_1064116;. Mouse anti-synapsin 1 (1:2000) – Synaptic Systems (cat. no. 106 001), species 
reactivity (hm/ms/rat/avian/zebrafish), Antibody Registry ID: AB_887805; Guinea pig anti-tau 
(1:2000) – Synaptic Systems (cat. no. 314 004), species reactivity (hm/ms/rat), Antibody Registry 
ID: AB_1547385. Secondary antibodies used were donkey Alexa Fluor 555/647 (1:2000).  
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Patch-clamp Electrophysiology 
Fire polished, filamented glass electrodes were pulled using a P-97 horizontal puller 
(Sutter Instrument Company) with open tip resistances ranging from 2.0–4.5 MΩ. The internal 
pipette solution contained (in mM): 120 K+ gluconate, 5 NaCl, 2 MgCl2, 0.1 CaCl2, 10 HEPES, 
1.1 EGTA, 4 Na2ATP, 0.4 Na2GTP, 15 sodium phosphocreatine; pH adjusted to 7.3 using KOH, 
osmolarity 291 mOsm. For the duration of recording, cells were continuously perfused with 
external solution at room temperature containing (in mM): 145 NaCl, 3 KCl, 2.5 CaCl2, 1.2 MgCl2, 
10 HEPES, 7 glucose, adjusted to pH 7.4 with NaOH. Neurons were recorded with an EPC10 
amplifier (HEKA Instruments) and Patchmaster software (HEKA Instruments). After acquiring 
gigaseal and break-in, neurons were given at least 2 minutes to stabilize and then a series of 
protocols to determine membrane excitability were performed. Action potentials were evoked in 
current clamp mode using a series of increasing 1 second ramp current injections. The first action 
potential of a train was used to determine threshold, defined as the voltage at which the first 
derivative of the membrane potential increased by 10 V/s. Rheobase was established from the 
step or ramp current pulse at which the first action potential was triggered. 
 
Calcium imaging  
The protocol for calcium imaging was the same as our previous studies in mouse [29-33]. 
Neurons were incubated for 45 minutes in 3 μg/mL (3µM) of the cell-permeant ratiometric calcium 
indicator Fura-2 AM (Molecular Probes) and then incubated in external solution (in mM): 130 
NaCl, 5 K, 2 CaCl2, 1 MgCl2, 30 Glucose, 10 HEPES for a 20-minute de-esterification prior to 
recording. Coverslips were positioned in a recording chamber and continuously perfused with 
external solution. Recordings took place at room temperature. Cells were viewed under an 
inverted microscope (Olympus Optical, Tokyo, Japan) and images were captured with a 
Hamamatsu Orca camera. Regions of interest encompassing all Fura-loaded cells were identified 
a priori and the ratio of fluorescence emission at an alternating excitation wavelength of 357 and 
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380 nm was recorded with SimplePCI Software. The experimental protocol consisted of a 2-
minute baseline followed by 30 second bath application of 100 μM histamine (Sigma, St. Louis), 
8 minutes of external solution wash, 30 seconds of 1mM chloroquine (CQ, Sigma, St. Louis), 8 
minutes external solution wash, 30 seconds of 100 μM mustard oil (MO, Sigma, St. Louis), 8 
minutes of external solution, 20 seconds of 200nM capsaicin (Sigma, St. Louis), 4-8 minutes of 
external solution, and 10 seconds of high KCl (50mM). Peak responses were determined by 
calculating the absolute increase in Fura-2 signal above baseline immediately prior to each 
stimulus. A change from resting level of ≥10% was set as the threshold for a response to a bath 
applied stimulus. Cells unresponsive to capsaicin or high K+ were excluded from physiological 
analysis. Calcium imaging recordings were performed on the 5th-7th days in vitro (DIV) to allow 
glial cells to peel off neurons and expose the plasma membrane for reliable Fura-2 signal 
visualization. For NTF treatment, cells from the same donor were treated with growth factor 
(100ng/ml human nerve growth factor, Peprotech; 100ng/ml human artemin, R&D Systems) or 
vehicle the evening prior to recording. The overall proportion of responders were determined for 
each donor and used for statistical comparisons (unpaired t test). Post-hoc measurements of cell 
diameter of responsive neurons were made in ImageJ using images obtained immediately prior 
to calcium imaging recording in SimplePCI.  
 
RNA sequencing of whole human DRG 
RNA and library preparation: Fresh DRG tissue from organ donors was cut into several sections 
and frozen at -80°C in RNAlater (Ambion) immediately after extraction.  For RNA preparation, 
DRGs were thawed, cut into small pieces, and put in TRIzol reagent (Life Technologies Inc).  
Tissue was then homogenized using an electric homogenizer and total RNA was isolated per the 
manufacturer’s instructions. Only samples with RNA integrity number (RIN) of > 7 were used for 
further analysis. Library preparation was done at the Genome Technology Access Center at 
Washington University (GTAC).  Briefly, 30 ng of total RNA were reverse transcribed and amplified 
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using the SMARTer Ultra low input RNA for Illumina Sequencing –HV (Clontech).  After cDNA 
preparation and shearing using an ultra-sonicator (Covaris), the libraries were prepared using 
VeraSeq Ultra DNA Polymerase for 12 cycles.  The forward primer used was: 
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCT. The 
reverse primer contains the unique reverse complement of the respective index nucleotides. The 
sequence of the reverse primer where "N" denotes the reverse complement of 7 nucleotides of 
the index is CAAGCAGAAGACGGCATACGAGATNNNNNNNGTGACTGG-
AGTTCAGACGTGTGCTCTTCCGA.  The purified cDNA yield was 16.5 ng/μl in 30μl.   
Nextgeneration sequencing and analysis: Single end sequencing was done on the Illumina 
HiSeq2500 platform following the manufacturer's protocol at the GTAC.   The raw demultiplexed 
RNA-seq reads were aligned with STAR version 2.0.4b 
(https://github.com/alexdobin/STAR/releases) (GRCh37 assembly). Low base quality reads and 
adaptors were clipped.  All known genes with raw counts were enumerated to the matching gtf 
file from the same reference build from Ensembl with Subread:featureCounts (version 1.4.5) 
(http://sourceforge.net/projects/subread/) using the Ensembl gene ID as the key.  Reads per 
kilobase of transcript per million mapped reads (RPKM) values were generated in R using raw 
counts.  We assessed sequencing performance for total number of aligned reads, uniquely 
aligned reads, number of genes and transcripts detected, and found less than 1% of ribosomal 
fraction and Spearman correlation of >0.9 between samples.   
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Results 
Establishing primary cultures of human dorsal root ganglia 
We developed a collaboration with the local organ procurement organization Mid-America 
Transplant to gain access to human dorsal root ganglia from deceased organ donors that have 
consented to tissue donation for research. After devising a surgical approach that provides a short 
post-mortem interval and minimal interference with further tissue procurement (Figure 1), we were 
able to obtain DRG from a number of donors of both sexes and varying ages (Table 2). We 
established a culturing protocol which follows our prior published studies of mouse sensory 
neurons very closely, utilizing the same coverslip coating solution, digestive enzymes, and culture 
medium [30-32, 34-37]. However, we incorporated a number of key modifications: a specifically 
designed preservation solution for transport, new instructions for tissue preparation, changes to 
enzyme digestion duration, and amount of time in culture prior to functional recordings [30-32, 34-
37]. Our studies using hDRG show that these adaptations maintain neuronal viability in transport 
and address several issues that arise from dissociation of substantially larger tissues with more 
abundant connective tissue than rodent DRG [19].  
Table 2. Donor demographics. (COD: cause of death, CVA: cerebrovascular accident).   
Donor # Age Sex Race/Ethnicity COD 
1 27 F White Head trauma 
2 30 F White CVA/Stroke 
3 31 F White Head trauma 
4 44 F Middle Eastern CVA/Stroke 
5 58 F White CVA/Stroke 
6 10 M White Head trauma 
7 21 M White CVA/Stroke 
8 22 M Black Anoxia 
9 41 M White Head trauma 
10 44 M White CVA/Stroke 
11 47 M White Head trauma 
 
The total number of coverslips obtained for functional studies depended on the number of 
ganglia cultured and cell density needed for the particular study. We found that one DRG can 
produce approximately 10-12 coverslips plated at a density of 500 cells/coverslip. However, this 
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can vary based on several factors, including DRG size (L1 is considerably smaller than L2-4), 
degree of dissociation, and general health of the tissue. Younger donors tended to have DRG 
that were easier to dissociate and neuron number and responses in culture were generally better. 
The density of 500 cells/coverslip provides an optimal number of cells for calcium imaging studies 
(~20-30 cells per viewing field at a 10x magnification) without excessive debris. Future studies 
can adjust the plating density to fit investigator needs. For example, plating at a lower density of 
200 cells/coverslip was suitable for electrophysiological recordings and immunocytochemical 
studies, but did not provide robust numbers for calcium imaging studies.   
Appearance of neurons in culture 
 While most rodent studies can be completed within 24 hours of cell plating, human sensory 
neurons were often tightly encased by satellite glia until the third or fourth day in vitro (DIV). During 
these first days in culture, glial cells peeled off allowing membrane access for patch pipettes or 
direct fluorescence visualization (Figure 3). More vigorous dissociation protocols can yield 
neurons free of supporting glia, but the health and survival of these neurons may be reduced [16]. 
The neurons produced with our extraction and dissociation protocol could be maintained in culture 
Figure 3. Dissociated hDRG neurons over time in vitro. Infra-red differential interference 
contrast microscopy (IR-DIC) images of cultured human sensory neurons.  (a) Initially, most 
dissociated neurons are encased in glial cells (white arrows) after 1 day in vitro (DIV), but can 
be identified by partially visible plasma membrane (white arrowhead). (b) As time in culture 
progresses, glia (white arrows) continue to peel off and adhere to the coverslip, exposing more 
of the plasma membrane. (c) After 6 DIV, the plasma membrane of most neurons is completely 
exposed, leaving them amenable to patch-clamp recordings and calcium imaging studies. 
Scale bars represent 20 μm.  
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for more than 10 days.  Whole ganglia and dissociated neurons can be studied using validated 
antibodies and standard immunocytochemical techniques to characterize cell morphology and the 
localization and expression of ion channels, receptors, and intracellular proteins (Figure 4) [28, 
30]. In addition, the coverslips used for functional studies by patch-clamp [16, 36-38] and calcium 
imaging [31, 36] can be fixed immediately after the experiment to allow for immunocytochemical 
studies of the same functionally-characterized neurons.    
 
Figure 4. Immunocytochemical analysis of cultured hDRG neurons. Collapsed confocal 
micrographs of immunolabeled neurons using standard techniques. (a) GFAP+ cells (purple) - 
presumably satellite glia that initially encase dissociated hDRG neurons – that have migrated 
onto the coverslip after 8 DIV. (b) Merged image with neurons immunolabeled for the 
cytoskeletal protein βIII-tubulin (green) and nuclei labeled with DAPI (blue). (c) TRPV1 
immunofluorescence (red), a common nociceptive marker in rodent DRG, was observed in 
subsets of cultured human sensory neurons. Nuclei are labeled with DAPI (blue). (d-f) 
Fluorescence images of cultured hDRG demonstrating extensive axonal process growth and 
branching marked by tau immunoreactivity (green) and a component of the synaptic vesicle 
release machinery, synapsin (red). Merged images are shown in (f) with DAPI-labeled nuclei 
(blue). (g-i) Cropped sections from the boxed areas in (d-f), showing an en passant-type 
presynaptic enlargement (synapsin, red) that formed along a sensory axon (tau, green). Scale 
bars represent 50 µm for panels (a-f), and 5 µm for the panels shown in (g-i).  
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Electrophysiological properties of hDRG neurons cultured in the presence or absence of 
growth factors  
Prior studies using primary cultures of hDRG neurons have applied human nerve growth 
factor (hNGF, 25 ng/mL), and human glial cell line-derived neurotrophic factor (hGDNF, 25 ng/mL) 
in the culture medium [16]. However, growth factors can directly modulate neuronal excitability 
and receptor expression, thus confounding any future studies on the effects of growth factors on 
pruriceptor sensitization. To determine if culturing with or without growth factors significantly 
impacted sensory neuron physiology, we used patch-clamp electrophysiology techniques to 
measure the basic excitability and membrane properties of the neurons in our cultures. We found 
that cells cultured without growth factors survive for more than 10 days without measurable effects 
on membrane properties. Gigaohm seals were obtained from >95% of selected neurons. We were 
careful to only patch neurons with a clearly visible soma devoid of satellite glial cells and exhibited 
a “smooth” membrane (Figure 3c). Whole-cell recordings were successful from >95% of these 
neurons, which included stable access resistance and a resting membrane potential 
hyperpolarized over -40 mV.  We found that neurons could be cultured in the absence or presence 
of the growth factors NGF and GDNF, and that chronic treatment did not affect cellular excitability, 
resting membrane potential, or soma size (Figure 5). The ability to maintain these neurons in 
culture in the absence of growth factors allows for future studies to determine the acute effects of 
growth factors on receptor expression and neuronal sensitization.  
 
Effects of NGF and artemin on human pruriceptors  
Very little is currently known about the human pruriceptive sensory neuron populations 
and whether they can be sensitized by neurotrophic factors. To investigate the direct effects of 
neurotrophic factors on dissociated hDRG neurons, we measured calcium responses to the 
pruritogens histamine and chloroquine, the TRPA1 agonist mustard oil, and the TRPV1 agonist 
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capsaicin. Prior to recording, neurons were maintained in culture without growth factors for 5-7 
days. Due to the precious nature of human tissue, we focused our studies on the growth factors 
we previously determined had effects on mouse pruriceptors: NGF and artemin. Once free of glial 
cells, neurons were treated with either a growth factor or vehicle overnight. On the next day, 
neurons were incubated with the fluorescent calcium indicator Fura-2AM and calcium responses 
Figure 5. Long-term culturing with neurotrophic factors does not alter hDRG 
excitability.  
Human sensory neurons were grown in the absence (black traces) or presence (red traces) 
of the neurotrophic factors NGF and GDNF (NTFs, 25ng/ml each, added to wells chosen 
randomly from all spinal levels). Recordings were performed between 4-9 DIV and cells were 
excluded from further analysis if the resting membrane potential was more depolarized than 
-40 mV. (a,b) Voltage traces illustrating action potential firing to 1 s depolarizing step (a) or 
ramp (b) current injections of 1-4 times current threshold (rheobase) of neurons grown in the 
absence (black traces) or presence of NTFs (red traces). Scale bars are 20 mV and 200 ms. 
(c,d) Summary plots of the number of action potentials elicited in neurons in response to 
both step (c) and ramp (d) stimuli, which were not significantly different between the two 
culturing conditions (two-tailed Mann-Whitney test, P values range from 0.143 to 0.964). (e,f) 
Quantification of step (e) or ramp (f) current threshold to elicit an action potential. No 
differences were found between the two groups (two-tailed Mann-Whitney test, P=0.738 for 
panel e, and P=0.361 for panel f). (g) Summary graph of the resting membrane potential for 
cells cultured in the absence or presence of NTFs, which were not significantly different (two-
tailed unpaired t-test; P=0.657). (h) Average soma diameters of neurons in both culturing 
conditions, which were not significantly different (two-tailed unpaired t-test; P=0.775). This 
suggests that the preferential survival of sub-populations of sensory neurons with different 
cell diameters was not influenced by either culturing condition. 19-30 cells were used for 
quantification per condition from four donors (4-30 cells for each measurement per donor), 
and all data are represented by the mean ± s.e.m of cells pooled across all donors.  
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to bath applied stimuli were recorded (Figure 6A-B). The average soma diameter of vehicle-
treated neurons in culture was 45 µm (± 9.9 µm SD, minimum: 16.8 µm, maximum 72.6 µm, 
n=118 neurons) (Figure 6C).  
 
Figure 6. Effects of NTFs on human sensory neuron responses to pruritogens. A. 
Calcium responses of dissociated hDRG neurons were measured using Fura-2AM (scale 
bar=100µm). B. Representative traces of calcium responses to the indicated bath-applied 
stimuli. C. Frequency histogram of cell diameter of responsive neurons. D. Distribution of 
stimulus-responsive neurons in control groups across all donors. Each data point represents 
an individual donor. E. Overnight treatment with NGF (100ng/ml) did not change the proportion 
of histamine-, chloroquine-, or capsaicin-responsive hDRG neurons (N=3 donors, 9-86 
cells/donor). F. Pretreatment with artemin (ARTN, 100ng/ml) did not affect the overall 
proportion of responsive neurons (N=3 donors, 10-42 cells/donor, unpaired t test).  
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We determined the relative distribution of pruritogen- and algogen-responsive neurons in 
our donor pool by calculating the proportion of vehicle-treated cells that responded to a given 
stimulus for each individual hDRG donor (n=6-8 donors) (Figure 6D).  To asses if human 
pruritogen receptors colocalize with TRP channels, we determined the proportion of neurons that 
responded to more than one stimulus (Table 3). Our data demonstrate that 87% of all histamine-
responsive neurons also responded to capsaicin, indicating that most histamine-sensitive 
neurons are also TRPV1-positive. More than half of histamine responders also responded to 
chloroquine, while only a third of chloroquine-sensitive neurons responded to histamine. and more 
than half also responded to chloroquine (Table 1). Chloroquine-responsive neurons were largely 
TRPV1-positive (74%), but more than half also responded to mustard oil. Most TRPA1-positive 
neurons responded to chloroquine, but few also responded to histamine or capsaicin. Overnight 
pre-treatment with NGF or artemin did not change the proportion of neurons that responded to 
histamine, chloroquine, mustard oil, or capsaicin (Figure 6E-F). These data indicate that the 
expression of human pruritogen receptors was not significantly affected by growth factor 
treatment, suggesting that the mechanisms behind NTF regulation of itch-sensitive neurons differ 
between mouse and human. 
Table 3. Functionally overlapping subpopulations of human sensory neurons.  
  % Responding to another stimulus 
   Histamine CQ MO Capsaicin 
Total 
responsive 
neurons  
Histamine+   56.00% 27.74% 87.27% 
CQ+ 36.84%   53.85% 73.68% 
MO+ 15.63% 65.62%   36.84% 
Capsaicin+ 40.00% 51.85% 24.14%   
 
RNA sequencing was used to quantify transcripts encoding pruritogen receptors, TRP 
channels, and neurotrophic factor receptors in whole human DRG. Transcriptome data were 
obtained from 5 donors, and confirm the presence of histamine receptor 1 (HRH1) and 2 (HRH2) 
transcripts, but none of the subtypes 3 and 4 (HRH3, HRH4) (Figure 7). Sequencing data further 
demonstrate the presence of MRGPRX1, the putative ortholog of the mouse MrgprA3/C11 
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pruritogen receptors. Interestingly, there was also a considerable amount of MRGPRX3 
transcripts detected, however, very little is known currently about the physiological role of 
MRGPRX3. Despite the high proportion of capsaicin-responsive neurons identified in our 
functional studies, TRPV1 transcript levels in whole DRG tissue were surprisingly low. TRPA1 
RNA was clearly detectable, though levels were not as high as the pruritogen receptor levels.  
Transcripts for the neurotrophic factor receptors TrkA (NTRK1) and Ret were detected, in addition 
to the GFRα 1-3 co-receptors. Consistent with prior mouse studies which demonstrate no role for 
persephin-GFRα4 signaling in sensory neurons, RNA sequencing found no GFRα4 transcripts in 
human DRG.  
 
Figure 7. Expression of pruritogen receptors, TRP channels, and growth factor receptor 
transcripts in hDRG.  RPKM values were averaged across individual donors (N=5). Data are 
presented as mean ± s.e.m.  
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Discussion 
 Several recent studies have identified species differences and validated molecular 
mechanisms using human sensory neurons, but few have provided a detailed description of 
extraction or culturing methodologies [13-16]. Here, we provide a detailed surgical extraction 
protocol for post-mortem access to human dorsal root ganglia (hDRG) immediately after organ 
procurement from consented donors. We demonstrate a culturing protocol that yields primary 
neurons that are amenable to a variety of functional approaches. In addition, we demonstrate that 
maintaining adult sensory neurons in culture without growth factors did not have a significant 
effect on their basic electrophysiological properties. We then demonstrate the distribution of 
pruriceptive and nociceptive populations in human DRG did not change in the presence of NGF 
or artemin. Future applications of this protocol have the potential to significantly impact our 
understanding of human neurophysiology and provide a platform for better translational studies 
of itch and pain mechanisms.  
 The extraction protocol we present here addresses several key issues that organ 
procurement organizations (OPOs) are likely to be concerned with when negotiating a research 
collaboration.  The ventral surgical approach through the abdominal cavity eliminates the need to 
move the donor during the procedure and preserves structural integrity of the body, thus 
significantly reducing post-mortem interval for DRG retrieval and resulting in minimal interference 
with other surgical procedures. Maintaining a sterile intraoperative field during the extraction 
allows subsequent tissue procurement of bone and skin, ensuring maximal utilization of donor 
tissues by the OPO. Importantly, this approach maintains the overall integrity of the donor body 
for funeral purposes, allowing access to all who consent to tissue donation for research without 
being restricted to donors who opt for cremation. 
Recent publications indicate that it may also be possible to culture human sensory 
neurons in the presence of other types of culture media [13, 14, 16]. Investigators may decide to 
incorporate the same enzymatic digestion, plating protocol, or culture media they have previously 
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used in animal model studies if the goal is to make direct comparisons to those prior studies. In 
such cases, this protocol can provide a positive control to confirm the viability of neurons as 
investigators adopt the extraction and dissection procedures in their own laboratories. Notable 
differences between our protocol and those previously described include the specific types of 
enzymes used (papain versus trypsin and DNase [13], or proprietary enzyme mixture [14, 16]) 
and the duration of enzymatic digestion (up to 3.5 hours in some studies). The type of culture 
medium and use of neurotrophic factors has also varied between studies, with several utilizing 
DMEM/F12-based media and all studies supplementing with varying concentrations of NGF 
and/or GDNF.  The successful culturing of human cells in a variety of different culture media and 
following different digestion methodologies suggests that individual labs may be able to adapt this 
protocol. Producing viable cultures of adult human sensory neurons using conditions similar to 
those used in previous studies of rodent neurons should reduce sources of variation and allow for 
more direct comparison between rodent and human sensory neurons.  
Previous studies demonstrate that NGF and artemin are increased in the lesional skin of 
patients with pruritic diseases [39-44]. In addition, in chapter 4, we demonstrated that NGF and 
artemin can increase the proportion of histamine- and chlorquine-sensitive neurons. To determine 
if the same mechanism exists in human sensory neurons, we tested neuronal calcium responses 
to pruritogens and algogens after incubation with NGF or artemin. Our data demonstrate that 
overnight pre-treatment with either NTF did not alter the proportion of histamine- or chloroquine-
responsive neurons. There was also no change in the proportion of capsaicin and mustard oil 
responders. Several factors may contribute to the observed differences between mouse and 
human responses to NTF treatment. The time spent in culture is longer in human experiments 
because it was necessary to wait for the glial cells to expose the plasma membrane of neurons 
to allow reliable calcium imaging recordings. Time in culture can be associated with transcriptional 
changes that could be a major contributor to the observed differences between mouse and human 
neurons. Future studies can address this by recording responses in mouse neurons that were 
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maintained in culture for longer. Alternatively, our results may simply indicate that human and 
mouse pruriceptive neurons are not modulated by NGF and artemin via the same mechanisms.  
Sequencing data from whole DRG tissue obtained from the same donors that provided 
neurons for functional studies confirm the presence of pruritogen and neurotrophic growth factor 
receptors. The detection of MRGPRX1 transcripts in hDRG and direct activation of sensory 
neurons by chloroquine strongly suggest a functional role for MRGPRX1 in human sensory 
neuron physiology. Despite activation by the same group of agonists, MRGPRX1 is not a true 
ortholog of the mouse MrgprA3 or MrgprC11 receptors. In heterologous systems, these receptors 
may engage different downstream mechanisms such as activation of different TRP channels 
(TRPV1 versus TRPA1) [23]. These fundamental differences in receptor signaling may contribute 
to the differences we observed in NTF responses of mouse versus human chloroquine-sensitive 
neurons.  
To our knowledge, this study is the first to apply ratiometric calcium imaging in dissociated 
human DRG cultures to characterize the human subpopulations that respond to pruritogens. The 
proportion of pruritogen- and algogen-responsive sensory neurons varied across donors, with 
histamine- and chloroquine-responsive neurons encompassing a larger proportion than what is 
generally reported in rodents. Most pruriceptive neurons responded to capsaicin, suggesting the 
possibility of a functional link between pruriceptor GPCR signaling and TRPV1. Future studies 
utilizing pharmacological interventions such as QX-314 and TRPV1 antagonists could directly test 
this hypothesis. The specific culturing protocol we have described can produce live adult sensory 
neurons that are amenable to physiological and biochemical measures and are similar to those 
studied in our previous publications [16, 19]. Dissociated cultures of human sensory neurons are 
a valuable resource that enables the precise manipulation of external factors to study neuronal 
physiology specific to humans and can strengthen future studies of itch and pain mechanisms.   
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Chapter 6 
Conclusions and Future Directions 
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 The work presented in this dissertation applies a multifaceted approach to address key 
questions about the molecular mechanisms that underlie the neurobiology of acute and chronic 
itch. In chapter 2, we utilized global genetic knock outs and acute pharmacological inhibition to 
characterize the contribution of PKCδ to acute histamine-induced itch. We applied the AEW model 
of dry skin itch to investigate the anatomical and functional changes associated with persistent 
itch in chapter 3. Our work identified the specific subset of Ret-positive fibers as likely contributors 
to dry skin-induced pruritus. In chapter 4 we investigated the effects of neurotrophic factors on 
pruriceptive responses, and found distinct roles for NGF and artemin the sensitization of 
histamine-dependent and -independent itch. Finally, in chapter 5 we demonstrated a novel 
method for the extraction and successful culturing of human sensory neurons, allowing us to 
perform the first studies to functionally characterize the pruriceptive subpopulations in humans.  
 
PKCδ as an intracellular mediator of itch 
In chapter 2, we investigated the role of the specific PKC isoform PKCδ in acute 
pruritogen-induced itch. Our studies indicate that PKCδ contributes to histamine-evoked 
scratching behavior, but may be dispensable for non-histaminergic itch induced by the pruritogens 
chloroquine and β-alanine. In the peripheral nervous system, PKCδ expression was restricted to 
small diameter sensory neurons, and was found in both peptidergic and nonpeptidergic neurons. 
Physiological studies of cultured adult DRG using genetic and pharmacological tools demonstrate 
that PKCδ mediates histamine-induced responses of sensory neurons. In addition, PKCδ may act 
downstream of the histamine receptor to modulate TRPV1 activity, as there was a significant 
reduction in capsaicin responses after histamine application. We conclude that PKCδ is involved 
in the sensory neuron responses that mediate acute histaminergic itch.   
Several questions remain about the precise role of PKCδ in histamine-induced itch. First, 
it is not clear whether PKCδ is engaged directly downstream of histamine receptor signaling or if 
it plays a more constant modulatory role in modulating or engaging downstream effector proteins 
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such as TRPV1. Future studies could determine if PKCδ is engaged downstream of histamine 
receptor activation by studying PKCδ translocation to the membrane. This assay has been 
validated previously, and can be further strengthened by the use of a PKCδ-KO-validated 
antibody [1]. The lack of reliable histamine receptor antibody availability can be overcome by 
combining calcium imaging measurements to identify histamine-responsive neurons with 
immunocytochemistry to probe for PKCδ translocation at specific time points after histamine 
activation. 
Previous findings from our lab showed that PKCδ deletion had no effect on acute pain, 
but significantly reduced CFA-induced inflammatory heat hyperalgesia, suggesting a potential 
function for PKCδ in nociceptor sensitization [2]. The expression of PKCδ in half of TRPV1-
positive neurons certainly suggests that it could be a modulator of TRPV1 expression or function. 
In addition, PKCδ may be involved downstream of PGE2, NGF, and IL-6 signaling [3-6]. Indeed, 
NGF-induced ERK phosphorylation was inhibited by the PKCδ pharmacological inhibitor rottlerin 
[5]. PKCδ has also been implicated in sickle cell-associated pain, paclitaxel-induced hyperalgesia, 
and NGF-TrkA induced axon growth in osteoarthritis [7-9]. Future studies could investigate 
whether there is indeed a functional link between PKCδ and inflammation-induced sensitization 
of TRPV1. Furthermore, PKCδ deletion could be tested in the context of inflammatory itch models 
such as dry skin and allergic contact dermatitis.  
Our studies demonstrate that despite a significant reduction in histamine-evoked itch, 
histamine responses were not completely inhibited, indicating that a substantial number of 
histamine-responsive neurons remain functional. This suggests other PKCδ-independent 
mechanisms also contribute to the signaling of histaminergic itch. These findings support the idea 
that the histamine-responsive population of sensory neurons is a heterogeneous group of cells, 
and distinct mechanisms may mediate downstream activation of histamine-dependent signaling 
cascades. This may be further reflected by the involvement of several histamine receptor 
subtypes, including H4R, whose role in histamine-induced itch is not clearly defined yet.  
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PKC activation is a key step in numerous signaling cascades, and several PKC isoforms 
have been identified in sensory neurons. However, isoform-specific effects on itch and pain 
remain poorly understood. A number of recent studies demonstrate inflammatory pain is mediated 
by PKCε, but this is one of the first studies to address the role of a specific PKC isoform in itch 
[10-19]. Ultimately, because of their extensive expression throughout the body, pharmacological 
inhibition of PKC isoforms may not provide an optimal approach to treating chronic pain or itch. 
However, by further dissecting the specific pathways associated with these kinases, we may be 
able to identify a downstream target that is more specific and amenable to clinical translation.  
 
Pruriceptor changes associated with models of chronic itch 
The work presented in chapter 3 demonstrates the specific anatomical and functional 
changes that are associated with a model of dry skin itch. Dry skin treatment resulted in a 
significant increase in scratching, but not wiping behavior, indicating that it elicits an itch-specific 
phenotype. The resulting intraepidermal hyperinnervation was independent of scratching, and 
included mostly Ret-positive non-peptidergic fibers. Interestingly, there were no changes in basic 
membrane excitability properties of trigeminal neurons that innervated the treated skin. However, 
there was an increase in the proportion of chloroquine-responsive trigeminal neurons, indicating 
de novo expression of pruritogen receptors resulting in an expansion of the pruritic subpopulation 
of sensory neurons.   
The acetone-ether-water (AEW) model is widely used as a model of chronic itch, because 
it shares several key characteristics with pruritic skin conditions. The skin changes observed in 
this model include epidermal hyperplasia, parakeratosis, and spongiosis, which are also 
frequently observed in the lesional skin of patients with atopic dermatitis and psoriasis. Barrier 
dysfunction is another key feature of this model that is also associated with pruritic skin diseases 
[20]. However, like xerosis in humans, the dry skin model is not marked by inflammatory 
infiltration, which is a common feature in most chronic itch conditions. A major question remains 
135 
 
regarding whether Ret+ fibers are also mediators of inflammatory itch. Inflammatory models of 
chronic itch include ovalbumin hypersensitivity resembling allergic itch, MC903/Vitamin D3 analog 
treatment which results in an atopic dermatitis-like phenotype, and trinitrochlorobenzene-induced 
contact dermatitis [21]. Future studies can utilize existing reporter lines such as RetEGFP or 
MrgprA3-TdTomato, to examine changes in pruritogen receptor expression and physiology under 
different types of inflammatory itch. These models may also allow a more chronic time scale to 
be applied, in order to determine the effects of long-term itch (>1-2 weeks) on pruriceptor plasticity 
and innervation. Identifying the distinct mechanisms or subpopulations of pruriceptors that 
mediate distinct types of itch could greatly aid in the development of more specific treatments by 
minimizing the side effects that frequently result from systemic immunomodulatory treatments.  
The “itch-scratch cycle” in chronic pruritic conditions is a vicious loop that results in further 
inflammation and damage to the skin, thereby eliciting even more itch, anxiety, and frustration in 
patients.  The use of Elizabethan collars allowed us to block the pro-inflammatory effects of 
scratching in order to determine the intrinsic changes that result from the induction of dry skin. 
Interestingly, epidermal hyperplasia and hyperinnervation still occurred, despite lack of 
mechanical stimulation and injury at the skin. This suggests that transepidermal water loss directly 
contributes to the pathological changes observed in the dry skin model, and it is these epidermal 
changes that likely drive the anatomical and functional effects associated with dry skin itch.  
 
Neurotrophic factors and their effects on itch 
In chapter 4, we examined the direct effects of neurotrophic factors on itch sensation and 
pruriceptor physiology. We found that acutely administered neurotrophic factors do not induce 
spontaneous itch or pain. Nerve growth factor (NGF) pretreatment selectively potentiated 
histamine-induced itch, but did not affect chloroquine-evoked scratching responses. On the other 
hand, artemin pretreatment potentiated chloroquine-induced itch, but appeared to inhibit 
histamine responses. Our data suggest distinct roles for NGF and artemin in the modulation of 
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histamine-dependent and histamine-independent itch. To further examine the mechanisms by 
which these growth factors sensitized pruritogen-induced itch, we tested the effects of NGF and 
artemin on histamine- and chloroquine- induced calcium responses. Acute 1-hour pre-treatment 
with NGF did not affect the proportion of histamine-responsive neurons. On the other hand, 
prolonged overnight incubation significantly increased the proportion of histamine responders, 
indicating that NGF likely induces de novo expression of histamine receptors in sensory neurons. 
Artemin increased the proportion of chloroquine-responsive neurons after both acute and 
overnight pre-treatment. These results indicate that neurotrophic growth factors can sensitize itch 
responses by upregulating the expression of pruritogen receptors via different mechanisms. 
Further studies are needed to determine the effects of artemin on histamine responses. 
Neurotrophic growth factors have long been studied as modulators of pain and several findings 
indicate NGF and artemin can directly sensitize TRPV1 function and upregulate its expression. 
Future studies can further dissect the downstream pathways underlying NGF- and artemin-
induced sensitization of itch [22]. A better understanding of NTF modulation of pruriceptive 
responses will ultimately further our understanding of the distinct neurbiological mechanisms that 
mediate itch versus pain.  
A second major concept addressed in the studies presented in Chapter 4 is the role of 
endogenous growth factor signaling in the maintenance of pruriceptors. In characterizing the 
TrkAF592A mutant, we determined that this single point mutation most likely results in aberrant TrkA 
receptor function. TrkAF592A mutants share several characteristics with TrkA/NGF knock-out 
phenotypes, including significant hypoalgesia and profound loss of peptidergic intraepidermal 
fiber innervation [23-26]. However, unlike the full loss of NGF/TrkA signaling, TrkAF592A animals 
survived well into adulthood and appeared to be less severely affected. This suggests that the 
TrkAF592A receptor is most likely hypomorphic, with enough residual function to support the 
survival of some sensory neurons. Perhaps the most interesting finding from this study is the lack 
of physiological effect on pruritogen-evoked scratching. In addition, calcium imaging studies 
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demonstrate histamine- and chloroquine-sensitive neurons are still present in TrkAF592A mutants. 
These results suggest that pruriceptor innervation and receptor expression may not be fully 
dependent on TrkA/NGF signaling. Further studies are needed to fully characterize which sensory 
populations are lost in order to begin to understand the loss of function in the TrkAF592A receptor. 
This study raises another interesting question regarding the dual expression of 
neurotrophic factor receptors in itch-sensitive neurons. If TrkA signaling is not important for the 
maintenance of pruriceptive neurons, the next obvious candidate is the receptor tyrosine kinase 
Ret, which regulates non-peptidergic neurons. Most Mrgpr family of receptors express Ret [27], 
and the MrgprA3-positive subset of pruriceptors is marked by the expression of both TrkA and 
Ret [28, 29]. Future studies can conditionally delete Ret in sensory neurons either acutely or 
during development [30], by taking advantage of the numerous available Cre-recombinase lines. 
A more specific role in pruriceptor function could be addressed by deleting Ret in MrgprA3-
positive neurons under the control of MrgprA3-Cre [28]. Furthermore, Ret deletion could be 
combined with TrkA deletion (TrkAF592A animals also harbor LoxP sites at the TrkA locus), to avoid 
neurotrophic factor receptor redundancy or compensation. The GFRα-GFL complex associates 
with Ret to induce phosphorylation of key Ret tyrosine residues, which then serve as docking sites 
for adaptor proteins such as Src, PLCγ, and Shc to activate downstream signaling cascades 
including the PI3K and MAPK [31]. Specific Ret tyrosine mutants could be studied to delineate 
whether specific downstream signaling mechanisms are involved in the maintenance versus 
sensitization of pruriceptor populations [32].  
 The work presented in chapter 4 addressed the effects of acutely applied neurotrophic 
growth factors on histamine- and chloroquine-induced itch. However, as mentioned previously, 
there are a number of other acute and chronic itch models that can be applied in order to study 
the role of neurotrophic factors and their receptors in the development or maintenance of chronic 
pruritus [21]. Understanding the effects of neurotrophic factors on neurophysiology is becoming 
an even more pressing issue as clinical trials using growth factors or growth factor-modulating 
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compounds are well underway for the treatment of a number of diseases, including sciatica, 
osteoarthritis, and Parkinson’s disease [33-38]. It is critical that we understand the wide range of 
effects of neurotrophic factors in order to inform future studies of the potential for clinically relevant 
adverse effects of new therapies.  
 
Human sensory neurons: a key step toward translation 
In chapter 5, we described a protocol we developed for the surgical extraction of human 
dorsal root ganglia (hDRG) from deceased organ donors. By applying a few key modifications to 
our mouse sensory neuron culturing protocol, we were able to dissociate and successfully culture 
adult human sensory neurons. These neurons could be maintained in culture for over 10 days 
and were amenable to several approaches including immunocytochemistry, RNA sequencing, 
and even patch-clamp electrophysiology and calcium imaging. The work on this project 
contributes tremendously to the field of pain and itch, by providing investigators with the means 
to generate human primary sensory neuron cultures. Many research institutions are located within 
or affiliated with a local medical center, where organ donation and transplantation takes place on 
a frequent basis. By providing a clear road map for the extraction process, other researchers 
could establish their own collaborations with local organ procurement organizations that will grant 
them access to donor tissue donated for research. Expanding preclinical access to human tissues 
has the potential to greatly improve the translation of preclinical findings into clinically effective 
treatments. Furthermore, the validation of key findings in target tissues will save tremendous 
amounts time and money.  
 Once we established that culturing without growth factors did not affect the basic 
electrophysiological properties of human neurons, we proceeded to determine whether we could 
observe the same effects of NGF and artemin on pruritogen-induced responses in vitro. Very few 
studies have been able to study functional responses of human sensory neurons, and to our 
knowledge, this is one of the first to characterize the human pruriceptive populations of cultured 
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hDRG [39-46]. Our findings demonstrate the proportion of histamine-, chloroquine-, mustard oil-, 
and capsaicin-responsive neurons and characterize the degree of overlap between these 
functional receptors. The application of NGF and artemin did not change the overall proportion of 
responsive human neurons, which contrasts with our observations in mouse neurons in chapter 
4. It is possible that the mechanisms of pruriceptor sensitization by neurotrophic factors are 
fundamentally different between species. However, it is also possible that there are inherent 
differences between the cultures due to the absolute age of human versus mouse neurons or the 
difference in time in vitro prior to recording secondary to the significant glial encapsulation of 
human neurons.  
 The protocol we have established for extraction and culturing of human DRG has opened 
the door to a number of exciting clinically relevant future studies and has resulted in several 
collaborations with research groups across the country. The extraction procedure itself has 
allowed us to also obtain spinal cord and intervertebral disc tissue. Future studies can begin to 
address key questions about the sensitization of nociceptors by intervertebral disc tissue, which 
can secrete pro-inflammatory cytokines and growth factors that are implicated in chronic low back 
pain. Spinal cord tissue can be used to investigate the sensory neuron inputs into the dorsal horn 
while serving as a model for studying synaptic transmission in humans.  
We have only begun to characterize the physiology of human sensory neurons. Future 
studies can start to validate or discover mechanisms behind sensory neuron sensitization by 
direct treatment with growth factors or other clinically relevant inflammatory compounds [46]. Co-
cultures using peripheral tissues such as keratinocytes can be used to build in vitro models of 
disease states to investigate the interactions between sensory neurons and their target tissues. 
Furthermore, advances in RNA sequencing technologies could allow for the full genomic 
characterization of the heterogeneous subsets of sensory neurons in human and determine how 
they differ from model organisms [29]. Transcriptome sequencing techniques can be combined 
with functional approaches such as calcium imaging and patch-clamp electrophysiology to identify 
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the transcriptional profiles of functionally-identified subsets of neurons. In conclusion, access to 
human neurons provides a vast number of opportunities to study normal and pathological neural 
processing, and will be an invaluable tool for the validation and generation of novel treatments.  
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